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Aflatoxins (AF) are fungal toxic metabolites of Aspergillus flavus and Aspergillus parasiticus,
which can frequently contaminate a variety of animal feed ingredients. Contamination of poultry
feed with AF is a major concern to the poultry industry due to their deleterious effects in
chickens such as reduced chicken performance and increased mortality. Additionally, the
consumption of AF-contaminated poultry products negatively affects public health due to their
carcinogenic and hepatotoxic effects. Therefore, it is critical to develop effective strategies for
controlling AF in poultry feed and aflatoxicosis in chickens. In this Ph.D. dissertation, the
efficacy of two plant-derived antimicrobials, namely carvacrol (CR) and trans-cinnamaldehyde
(TC), was investigated for reducing A. flavus and A. parasiticus growth and AF production in a
broth system and in chicken feed. Moreover, the efficacy of CR and TC for reducing
aflatoxicosis in chicken embryos and broiler chickens was also studied. Additionally, hepatic
transcriptome of chickens exposed to AF with or without CR/TC supplementation was
performed to elucidate the mechanisms behind the protective effects of phytochemicals to
chickens. Results revealed that CR and TC significantly inhibited growth of AF-producing molds
and AF production in potato dextrose broth and chicken feed (P < 0.05). Real-time quantitative
PCR results revealed that CR and TC down-regulated the expression of major genes associated
with AF biosynthesis (P < 0.05). In addition, CR and TC decreased AF-induced adverse effects
in chicken embryos by improving the survivability and the weight of chicken embryos when
exposed to AF (P < 0.05). Moreover, in-feed supplementation of CR and TC ameliorated
aflatoxicosis in chickens, where phytochemical supplementation significantly decreased relative
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liver weight, improved relative bursa of Fabricius weight, and reduced AF-induced toxic effects
in the liver of birds (P < 0.05). Results of the hepatic transcriptome demonstrated that several
pathways and genes associated with hepatic diseases and lipid metabolism were affected by the
AF treated diet; however, supplementation of CR and TC to the AF diet modulated genes
involved in these pathways. Collectively, these results indicate that CR and TC could potentially
be used as feed additives to control aflatoxicosis in chickens.
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Chapter I
Introduction

1

Aflatoxins (AF) are a group of toxic metabolites of Aspergillus flavus and
Aspergillus parasiticus, which can frequently contaminate feed ingredients, including
peanuts, corn, and cottonseed (Oguz et al., 2000; Sur and Celik, 2003). Contamination
of poultry feed with AF is a major concern to the poultry industry since aflatoxicosis
in chickens results in significant economic losses due to poor feed utilization,
decreased body weight, reduced egg hatchability, and increased mortality (Qureshi et
al., 1998; Tessari et al., 2006; Oguz, 2011). Since the first outbreak of AF
contamination that occurred in 1960, the negative effects of AF in poultry have been
widely investigated (Giambrone et al., 1978; Celik et al., 1996; Sur and Celik, 2003).
Once ingested by chickens, AF can accumulate in most of the soft tissues and fat
depots of the chicken resulting in hemorrhagic and enlarged liver (Leeson et al., 1995;
Bintvihok et al, 2002). In addition, AF residues found in poultry meat and eggs
(Jacobson and Wiseman, 1974; Sudhakar, 1992; Qureshi et al, 1998) pose a
significant health hazard to humans due to their carcinogenic, teratogenic, and
mutagenic properties (Ross et al., 1992; Bintvihok et al., 2002).
Among the 16 types of AF identified in feed, AFB1, B2, G1, and G2 constitute
the major ones (Leeson et al., 1995). Aflatoxin B1 is one of the most potent
hepatocarcinogens, and its active metabolite, 8, 9, -epoxide, metabolized by P450
cytochrome in liver, binds to proteins and forms adducts such as AFB1-lysine in
albumin. Furthermore, this active metabolite binds to guanine residues in DNA
forming guanyl-N7 adducts, and initiates the formation of hepatocarcinomas (Hsu et
al., 1991). Due to its carcinogenic properties, AFB1 has been listed as a group I
human carcinogen by the International Agency for Research on Cancer (Yunus et al.,
2

2011).
In light of the risks associated with aflatoxicosis in chicken, the U.S. Food and
Drug Administration (FDA) has established guidelines for the maximum toxin level
permitted in poultry feed, which is 20 ppb in corn and peanut products for chicks, and
100 ppb in feed for adult chickens (FDA, 2009). Thus, it is critical to develop
scientifically validated strategies for controlling AF in poultry feed and aflatoxicosis
in chickens to protect public health, bird health, and to ensure the economic viability
of the poultry industry.
The overall objective of this dissertation was to investigate the efficacy of two
natural

plant-derived

antimicrobials,

namely

carvacrol

(CR)

and

trans-

cinnamaldehyde (TC), for controlling aflatoxicosis in chickens. The specific
objectives were:
1.

To study the effect of CR and TC on A. flavus and A. parasiticus growth,
AF production, and expression of toxin production genes in a broth
system and in chicken feed during long-term storage.

2.

To determine the efficacy of CR and TC in reducing AF-induced toxicity
in chicken embryos.

3.

To determine the efficacy of in-feed supplementation of CR and TC in
reducing aflatoxicosis in chickens.

4.

To investigate the effect of in-feed supplementation of CR and TC on the
hepatic transcriptome of chicken exposed to AF.

3

Chapter II
Review of Literature

4

1.

Production of aflatoxin: Aspergillus flavus and Aspergillus parasiticus

1.1 Biochemical and physiological characteristics of Aspergillus flavus and
Aspergillus parasiticus.
Fungi are commonly found in a wide range of climate zones, especially between
latitudes 16o and 35o in warm areas (Klich, 2007). Fungal sclerotia are able to survive
in soil under severe environmental conditions and produce conidia dispersed by air or
soil movement, leading to a population increase under hot and drought weather
conditions (Wicklow et al., 1993; Payne, 1998). Conidia that are distributed through
air are capable of infecting crops such as maize, tree nuts, peanut seed and cottonseed
(Horn and Pitt, 1997; Cotty, 2001). Fungal colonization of crops could be enhanced
with favorable environmental conditions (such as hot and dry) and the damage caused
by insects and birds (Horn and Pitt, 1997; Payne, 1998). Insect infestations of crops
such as the lesser cornstalk borer (Elasmopalpus lingosellus Zeller), nitidulid beetles
(Nitidulid), and rice weevil (Sitophilus zeamais) are associated with enhanced
infections of Aspergillus spp. (LaPrade and Manwiller, 1977; Lussenhop and
Wicklow, 1990).
Link (1809) first used the name Aspergillus flavus to describe a mold species as

5

well as a group of closely related species. In general, Aspergillus flavus is known as a
velvety, yellow to green or brown mold with a golden to red-brown reverse (Hedayati
et al., 2007). Aspergillus flavus isolates can be divided into two phenotypic types
based on the characteristics of the sclerotia that are produced; the S strain produces
numerous small sclerotia (average diameter ,400 mm) and the L strain produces fewer
but larger sclerotia (Cotty, 1989). Raper and Fennell (1965) considered A. flavus
group to contain nine species and two varieties, including A. flavus, A. flavus var.
columnaris, A. parasiticus, A. oryzae, A. oryzae var. effusus, A. zonatus, A. clavatoflavus, A. tamarii, A. flavo-furcatis, A. subolivaceus and A. avenaceus. Aspergillus
flavus and A. parasiticus are closely related fungi that are known to contaminate
numerous crops in the field, during harvest, in storage, and during processing, and can
grow as unspecialized saprophytes on crop debris in soil (Wicklow and Donahue,
1984).
Susceptibility of crops to A. flavus and A. parasiticus infections varies. For
example, A. flavus infects a wide range of plant hosts, whereas A. parasiticus is
generally limited to ground crop hosts due to preferences for the suitable growth
temperature (Horn et al., 2009). Aspergillus flavus as an opportunistic pathogen of

6

agricultural crops infects oil-containing crops such as maize, peanut, and cottonseed,
and it is considered to be the dominant species compared to A. parasiticus on maize
and cottonseed. Aspergillus parasiticus on the other hand, appears to be adapted to a
soil environment, so it is prominent in peanuts (Horn et al., 1998).
1.2 Aflatoxin production
Mycotoxins are fungal secondary metabolites that are harmful to the health and
development of animals or humans. The first outbreak of aflatoxin poisoning was
reported in turkeys, which was identified as Turkey “X” disease in England in 1960s
causing the death of 100,000 turkeys (Blount, 1961; Van der Zijden, 1962). The
Turkey “X” disease led to the discovery of aflatoxin from the groundnut meal
contaminated by A. flavus (Hesseltine, 1979), and the term “aflatoxin” came from
“Aspergillus flavus toxin” (Yu et al., 2004). Among the 16 different types of aflatoxins,
aflatoxin B1, B2, G1, and G2 are the major toxins that contaminate crops (Goldblatt,
1969). Aflatoxin B1 (AFB1) is one of the most potent hepatocarcinogens, and its
active metabolite, 8, 9, -epoxide, metabolized by cytochrome P450 (CYP450) in liver,
binds to proteins and forms adducts such as AFB1-lysine in albumin. Furthermore,
this active metabolite binds to guanine residues in DNA forming guanyl-N7 adducts,
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and initiates the formation of hepatocarcinomas (Hsu et al., 1991). Due to its
carcinogenic properties, AFB1 has been listed as a group I human carcinogen by the
International Agency for Research on Cancer (Yunus et al., 2011).
As described previously, based on the size of the sclerotia, A. flavus can be
characterized into L strains (sclerotia > 400 mm) and S strains (sclerotia < 400 mm),
and it has been confirmed that both A. flavus S and L strains produce aflatoxins B1
and B2, but A. flavus S strains and A. parasiticus may also produce aflatoxins G1 and
G2 (Cotty, 1989, Yu, 2004; Horn et al., 2003). Other than aflatoxins, A. flavus is able
to produce toxins such as sterigmatocystin, cyclopiazonic acid, kojic acid, and betanitropropionic acid.
In general, warm and humid conditions (30°C and water activity of 0.99) at preharvest and post-harvest levels, and during transport or storage time, promote
toxigenic Aspergillus spp. colonization, followed by aflatoxin production and
accumulation in crops and feedstuff (Cotty and Jaime-Garcia, 2007; Rawal et al.,
2010). In addition, proper substrates, incubation time, and CO2 levels may also affect
the production of aflatoxins (Schindler et al., 1967; Schroeder et al., 1967; Trenk et al.,
1970; Gqaleni et al., 1997; Medina et al., 2014). Once food-producing animals ingest
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aflatoxin-contaminated feed, aflatoxin residues can be transferred to milk, meat and
eggs of livestock and poultry (CAST, 2003; Pandey and Chauhan, 2007; Aly and
Anwer, 2009). Hence, aflatoxin contamination is considered as a human food safety
risk in both plant and animal products. Although aflatoxin contamination happens at
both pre- and post-harvest levels, post-harvest aflatoxin contamination of seeds is the
major problem because of improper storage practices, primarily under excessive
moisture, and insect activity (Cotty, 1997).
Aflatoxins, as secondary metabolites of molds have a very complicated
biosynthesis pathway, which involves a cluster of at least 29 genes in a contiguous 75
kb region, and more than 23 enzymatic reactions are required to synthesize AF (Yu et
al., 2004, Ehrlish et al., 2005). In the aflatoxin biosynthesis pathway, aflC, nor1, norA
and ver1 are the principal genes related to aflatoxin production, where aflC involved
in the conversion of acetate to norsolorinic acid (NOR) plays a critical role in early
aflatoxin biosynthesis pathway. Ehrlich and Cotty (2004) reported that nonsense
mutation of this gene resulted in the loss of aflatoxin synthesis in molds. Similarly,
nor1 and norA are involved in the conversion of NOR to averatin (AVN), where NOR
is the key structural intermediate in the pathway (Bennett, 1981). Moreover, nor1 has
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been used as a potential marker gene to discriminate between toxigenic or
nontoxigenic strains (Mayer et al., 2003). ver1 encodes an enzyme that converts
versicolorin (VERA) to demethyl-sterigmatocyin (DMST), which is located in the last
step of aflatoxin biosynthesis pathway before the intermediates start differentiating
into different types of aflatoxins (AFB1, B2, G1, and G2).
1.3 Economic importance
Aspergillus flavus colonization does not necessarily reduce the yield of affected
crops, but causes economic losses due to aflatoxin contamination. Worldwide,
aflatoxins are considered a major public health problem, especially in developing
countries, where long-term food storage is often inadequate for high heat and
humidity, which encourage mold growth (Eaton and Gallagher, 1994). The economic
impacts attributed to aflatoxin are incurred directly by losses in crops, livestock, and
dairy, and indirectly by a recurring expenditure in quality-control programs, research
and education, lower foreign exchange earnings, and increased storage and packaging
costs of vulnerable commodities (Mishra and Das, 2003). Mycotoxin contamination
in agriculture has caused an estimated average economic loss at approximately one
billion dollars per year in the United States (Vardon et al., 2003), and among all the
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mycotoxins, aflatoxin contamination is the most serious one worldwide (CAST, 2003).
According to Rubens and Cardwell’s report, aflatoxin contamination resulted in an
annual economic loss of approximately $25 million on peanut in the state of Georgia,
$2-15 million losses on maize in Texas, Mississippi, and Arizona, $3.8 million on
walnuts in California, and $2.3-4.7 million in California (Rubens and Cardwell, 2005).
Although dollar losses are not available from developing countries in Asia and Africa,
the losses in these countries are considered to be more severe than in the United States
(Yu et al., 2005). In an effort to control aflatoxin exposure to animals and humans, the
US Food and Drug Administration (FDA) has set a limit of 20 ppb of aflatoxin in
food for human consumption, 100 ppb for animal consumption, and 0.5 ppb in milk
(Georgianna and Payne, 2009).
2.

Etiology of Aflatoxins
In the early 1960s, Turkey “X” Disease, which was characterized as an outbreak

of hepatotoxic disease, led to the discovery of aflatoxins (Asplin and Carnaghan, 1961;
Eaton and Gallagher, 1994). Soon after the outbreak of Turkey “X” disease,
researchers discovered that aflatoxin contamination was responsible for another
outbreak of hepatocellular carcinomas in hatchery-reared rainbow trout, a species for
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which background tumor rates were very low (Halver, 1969). Since the discovery of
the aflatoxins, researcheres have been intensively studying their toxicity,
carcinogenicity, mutagenicity, and teratogenicity to humans and animals under
different conditions such as sex, age, nutritional status, and the effect of chemicals
(Ellis et al., 1991).
2.1 Biotransformation of aflatoxin in liver
Once AFB1 enters the host, it is first absorbed in the small intestine, especially
the duodenum (Gratz et al., 2005). However, because enzymes present in the small
intestine have a low affinity for AFB1 (Guengerich et al., 1996), the majority of the
absorbed aflatoxins is metabolized in the liver, where AFB1 initiates its
carcinogenicity through bio-activation (Eaton and Gallagher, 1994), including four
reactions: (1) O-demethylation, (2) hydroxylation, (3) epoxidation, and (4)
ketoreduction (Massey et al., 1995). During the biotransformation of AFB1 in liver,
AFB1 becomes an intermediate form, AFB1-8,9-epoxide (AFBO), and then exerts its
hepatocarcinogenic effects by binding with DNA, RNA, and proteins in the liver
(Eaton and Gallagher, 1994; Leeson et al., 1995; Bedard et al., 2006).
2.1.1 Hydroxylation and O-demethylation of AFB1
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When AFB1 reaches liver, it can be oxidized to its hydroxylated metabolites,
including AFM1, AFP1, and AFQ1 by the microsomal cytochrome P450-dependent
monooxygenases. For example, AFQ1 is formed via 3a hydroxylation of AFB1,
whereas AFM1 is produced by 9a hydroxylation of AFBl, and AFP1 is formed
through an O-demethylation of AFB1. In general, toxicities of these hydroxylated
metabolites are lower than their parent compound (Hsieh et al., 1974). For instance,
AFMl isolated and identified as an AFBl metabolite in milk is approximately 30% as
carcinogenic as AFB1 in trout (Holzapfel and Steyn, 1966; Sinnhuber et al, 1974),
and approximately 10% as carcinogenic in rats (Hsieh et al., 1984). Similarly, it has
been shown that AFQ1 only exhibits approximately 1% of the toxicity of AFB1 in
rainbow trout (Hendricks et al., 1980).
In animals, the O-demethylation of AFB1 produces AFP1 (Wong and Hsieh,
1980). Kirby et al. (1994) observed an increase in AFP1 concentrations in the liver
from the patients with diagnosed liver tumors when compared to the normal liver
tissue. Moreover, AFP1 was also highly correlated to all urinary AFB1 metabolites in
humans with liver cancer (Ross et al., 1992).
2.1.2 Epoxidation of AFB1
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Microsomal cytochrome P450 (CYP450)-dependent epoxidation of the terminal
furan ring of AFB1 results in the formation of AFBO, which can be disrupted by
interception with trapping agents such as DNA, and also with glutathione (GSH) and
glutathione S-transferases (GSTs). AFBO may be conjugated enzymatically with GSH,
which serves as a critical pathway for AFB1 detoxification (Eaton and Gallagher,
1994). Therefore, the ratio of AFB1 epoxidation and GSH conjugation affects the
amount of AFB1-DNA adduct formation. For both chemical and enzymatic reactions,
epoxidation of AFB1 results in the formation of endo AFB1-8,9-epoxide or exo
AFB1-8,9-epoxide (Raney et al., 1992; Eaton and Groopman, 1994). The exo-epoxide
is the isomer implicated in the alkylation of DNA, with its reactivity being at least
1,000 fold greater than that of the endo-epoxide (Lyer et al., 1994). Therefore, exoepoxide is more likely to form AFB1-DNA adducts and it is considered to be more
mutagenic than the endo-epoxide.
Several researches confirmed the involvement of CYP450 enzymes in the AFB1
bio-activation, including members of 1A, 2B, 2C, and 3A subfamilies in experimental
animals (Yoshizawa et al., 1982). In humans, multiple CYPs are involved in AFB1
biotransformation, including CYP1A2, CYP2A3, CYP2B7, CYP3A3, CYP3A4, and

14

CYP2A13 (Shimada and Guengerich, 1989; Massey et al., 1995). Human CYP3A4 is
activated at high AFB1 concentrations, while CYP1A2 has a high affinity at lower
concentrations (Ramsdell et al., 1991; Gallagher et al., 1994). The rate of AFBO
formation also varies in different species based on the activity of the CYP450
enzymes, for example, human CYP450 enzymes produce only approximately of 25%
AFBO than that in rats (Ramsdell and Eaton, 1990).
Although CYP450 enzymes are responsible for a majority of the AFB1
epoxidation, other enzymes such as prostaglandin H synthase (PHS), lipoxygenases
(LOX), and a cytosolic NADPH-dependent reductase can also activate AFB1
epoxidation through CYP450-independent pathways (Battista and Marnett, 1985; Liu
and Massey, 1992; Massey et al., 1995). Battista and Mamett (1985) reported that
PHS-dependent epoxidation of AFB1 can co-occur with CYP450-mediated AFB1
epoxidation. Also, LOX from liver and kidney can activate AFB1 to DNA-bound
derivatives (Liu and Massey, 1992). Furthermore, the kinetics of LOX-dependent
hepatic DNA binding suggests that this pathway could be particularly active at dietary
levels of AFB1 exposure (Liu and Massey, 1992).
2.1.3. Ketoreduction of AFB1
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Ketoreduction of AFB1 results in the formation of aflatoxicol by reduction of the
1-keto-group through a cytosolic NADPH-dependent reductase (Salhab and Edwards,
1977; Woloshuk and Prieto, 1998; Dohnal et al., 2014). Aflatoxicol can be further
metabolized to aflatoxicol-M1 (Loveland et al., 1988). Aflatoxicol has been reported
to be a potent mutagen, and is approximately 50% as carcinogenic as AFB1 and 70%
as mutagenic as AFB1 in trout (Schoenhard et al., 1981; Coulombe et al., 1982;
Ottinger et al., 2000). Aflatoxicol can also be rapidly reversed to AFB1 by
dehydrogenase, thereby increasing the physiological half-life of AFB1 (Salhab and
Edwards, 1977; Woloshuk and Prieto, 1998; Dohnal et al., 2014). Liver from species
that are sensitive to AFB1 typically exhibits high ratios of AFB1 reductase versus
aflatoxicol dehydrogenase activities than the less sensitive species such as rodents
(Salhab and Edwards, 1977; Woloshuk and Prieto, 1998; Dohnal et al., 2014).
3.

Aflatoxicosis in humans
Numerous epidemiological studies of human populations exposed naturally to

aflatoxin-contaminated foods have been reviewed extensively. Aflatoxicosis in
humans can be characterized into acute and chronic conditions based on the
concentration of consumed aflatoxins and the period of time that the hosts are
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exposed to the toxin (Williams et al., 2004). Acute aflatoxicosis, resulting from
consuming a high-concentration of aflatoxin over a short period of time, often results
in outbreaks in humans. For example, Kenya experienced the most serious recent
outbreak of aflatoxin contamination in 2004 with 317 cases and 125 reported deaths
(Azziz-Baumgartner et al., 2005). Low-dose aflatoxin consumption over an extended
exposure time results in chronic aflatoxicosis, which can cause in immune
suppression, stunting, and liver cancer in humans. Approximately 4.5 billion people
are at risk of chronic exposure to aflatoxin-contaminated food (Hamid et al., 2013).
Several epidemiological studies have supported the correlation between the
dietary aflatoxin intake and the incidence of human hepatocellular carcinoma, where
AFB1 is the most hepatocarcinogenic mycotoxin and the main contributor to the high
rate of hepatocellular carcinoma (Hamid et al., 2013). One of the mechanisms of
aflatoxin-induced liver cancer is from a mutation in the tumor suppressor gene, p53,
in the liver (Hsu et al., 1991). The rate of hepatocellular carcinoma was found to be
increased by at least 30-fold in the presence of both aflatoxin and the hepatitis B or C
virus infection, creating severe health problems for people living in developing
countries, where both aflatoxin and hepatitis viruses are common (Kuang et al., 2005;
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Groopman et al., 2008). Similarly, Ross et al. (1992) analyzed over 18,000 urine
samples for the presence of the N7-guanine adduct of aflatoxin. In their study, 22
urine samples from the subjects who developed liver cancer during the analysis, were
examined for the presence of hepatitis B virus surface antigen and aflatoxin exposure
biomarker. Results revealed that aflatoxin exposure alone (hepatitis B antigennegative) yielded a relative risk of about two; hepatitis B virus antigen positive status
alone (aflatoxin exposure negative) yielded a relative risk of about five. However,
combined exposure (aflatoxin plus hepatitis B virus positive antigen) yielded a
relative risk of over 60 (Ross et al., 1992).
In order to assess chronic aflatoxin exposure, studies have focused on the
development of accurate and applicable biomarkers of exposure to aflatoxin such as
aflatoxin-related urinary metabolites due to dietary aflatoxin intake (Groopman et al.,
1988; Groopman et al., 1992; Qian et al., 1994). Zhu et al. (1987) conducted a study
in China and found a high correlation score of 0.65 between total dietary AFB1 intake
and urinary AFM1 excretion in 32 households in the Guangxi region. Similarly, Wild
and co-workers (1992) found a high correlation between dietary intake and urinary
excretion of aflatoxin metabolites; AFB1-N7-guanine adduct in urine represented the
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most reliable urinary biomarker of aflatoxin exposure (Groopman 1988; Qian et al.,
1994). Albumin-lysine-AFB1 adduct is another biomarker of aflatoxin exposure; Hall
and Wild (1994) found a 10-fold fluctuation in urinary aflatoxin metabolites over a 4day period and ~ 2-fold fluctuation in albumin-AFB adducts in the same period. In
addition, in the same case-control study which investigated the relationship between
aflatoxin and liver cancer in China, albumin-AFB1 adduct concentration in peripheral
blood was correlated with individual dietary aflatoxin intake (Hall and Wild, 1994).
4.

Aflatoxicosis in poultry
Studies conducted during the last five decades have investigated the negative

effects of aflatoxins on various farm animals, including effects on animal
performance and metabolism, metabolism of the toxin, and carryover of toxic residues
in animal products (Diaz, 2005). Animal susceptibility to the acute effects of
aflatoxicosis varies widely. The LD50 (mg/kg body weight) of AFB1 is 0.3 for
ducklings, and 6.0 for chickens. The variation in the sensitivity of various animal
species towards AFB1 is believed to be linked with differences in the toxin’s
metabolism and the types of metabolites formed (Emafo, 1976). In general, domestic
turkeys (Meleagris gallopavo) and ducks (Anas platyrhynchos) are more sensitive to
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both the acute and chronic toxicity of AFB1 than chickens (Gallus gallus) except
during embryonic development (Giambrone et al., 1985; Klein et al., 2000; Rawal et
al., 2010). During chicken embryonic development, a LD50 dose of AFB1 to chicken
embryo could be as low as 0.3 mg/kg body weight (Cullen and Newberne, 1993;
Leeson et al., 1995). Even when toxin exposure does not cause mortality or morbidity,
aflatoxicosis contributes directly and indirectly to losses in the poultry industry.
4.1 Economic impact of aflatoxicosis in poultry
The Food and Agriculture Organization (FAO) reported that 25% of the world’s
grains are contaminated by mycotoxins, and aflatoxin contamination is the most
common among them. The economic losses due to aflatoxin contamination to the US
poultry industry exceeded $143 million annually (CAST, 1989). Aflatoxicosis in
poultry resulting from the ingestion of aflatoxin contaminated feed negatively affects
production values, causing severe economic losses to the poultry industry. Dietary
exposure to aflatoxins leads to a decrease in performance, including decreased body
weight gain and absolute body weight in both chickens and turkeys (Giambrone et al.,
1985; Quezada et al., 2000; Pandey and Chauhan, 2007). In addition, aflatoxicosis
reduces feed intake and decreased efficiency of nutrient usage, which increases the
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feed conversion ratio causing poultry to require more feed to produce meat and eggs
(Verma et al., 2004; Yarru et al., 2009; Lee et al., 2012). For example, Dersjant-Li
and coworkers (2003) reported that each mg of AFB1/kg diet would decrease the
growth performance of broilers by 5%. Similarly, Miazzo et al. (2000) found a
reduction of 11% in body weight gain when 2.5 mg AFB1/kg diet was fed to broilers
from 21 to 42 days of age as compared to birds fed a diet devoid of aflatoxin
contamination. Aflatoxicosis also affects the reproductive performance of poultry.
When layer hens were fed AFB1 in their diet, age to maturity was increased and egg
production decreased (Azzam and Gabal et al., 1998; Garlich et al., 1973; Howarth et
al., 1976; Khan et al. 2014).
4.2 Hepatotoxicity of aflatoxin in poultry
It is well known that the liver is the primary organ of aflatoxin bio-activation and
detoxification (Giambrone et al., 1985; Klein et al., 2000; Rawal et al., 2010). Micco
and colleagues (1988) reported that when chickens were exposed to an aflatoxin
contaminated diet, AFB1, AFM1, and aflatoxicol were detected in liver, kidneys, and
thigh muscles. Longer exposure to aflatoxin contaminated feed leads to an increase in
the relative weight of liver and causes pale or yellowed pigmentation in poultry
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(Verma et al., 2004; Yarru et al., 2009; Lee et al., 2012). At the cellular level,
increased vacuolation of AFB1-exposed hepatocytes allows high levels of lipids to
accumulate (Sims et al., 1970; Giambrone et al., 1985; Oliveira et al., 2002). Steatosis
is therefore responsible for the changes in liver color and size during aflatoxicosis.
Recent studies have shown that CYP2A6 and to a lesser extent CYP1A1 are
responsible for the bio-activation of AFB1 into the epoxide form in the liver of
chickens and quail (Diaz et al., 2010).
Modern broilers are known to gain more weight by utilizing less feed in a shorter
time (Qureshi and Havenstein, 1994; Dozier et al., 2008). Because of the
hepatotoxicity of AFB1, it might result in more profound negative effects in birds
with more efficient nutrient conversion demanding faster hepatic metabolism. Both
acute and chronic aflatoxicosis in poultry cause AFB1-induced liver damage,
including focal necrotic hepatocytes or hemorrhages (Newberne and Butler, 1969;
Giambrone et al., 1985; Klein et al., 2002). Acute damage initiates inflammatory
responses and results in leukocyte infiltration and proliferation in the liver (Cova et al.,
1990). Additionally, short-term exposure to high doses of aflatoxin causes morbidity
and mortality due to extensive liver damage (Rawal et al., 2010). In poultry, chronic
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AFB1 consumption is mutagenic and causes remodeling of liver tissues. Hyperplasia
of bile duct epithelial cells or development of oval cells, followed by periportal
fibrosis and nodular tissue regeneration have been reported (Cova et al., 1990;
Ortatatli and Oguz, 2001).
AFB1 forms adducts with biomolecules causing damage to hepatocytes that
impairs metabolic functions of the liver. As the liver is responsible for the production
of most circulating proteins (Rauber et al., 2007), aflatoxicosis reduces the
concentrations of albumin, globulin, cholesterol, and triglyceride levels in serum,
whereas AFB1 at levels of 1 mg/kg decreases the total serum protein and albumin
contents (Quezada et al., 2000; Siloto et al., 2013). In addition, AFB1 also diminishes
the levels of multiple blood coagulation factors that are produced in the liver of
chickens and turkeys (Witlock and Wyatt, 1981; Fernandez et al., 1995). Protein
content likely declines because AFB1-DNA adducts inhibit transcription or
translation and AFB1-lysine adducts result in protein degradation or excretion.
4.3 Embryotoxicity of aflatoxins in poultry
AFB1 and its metabolites can be transferred from the laying hen into the albumin
and yolk of the egg (Oliveira et al., 2000; Oliveira et al., 2003). Signs of aflatoxicosis
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in chicks and poults have been noted if they are exposed to AFB1 during development
(Khan et al., 2014). Transfer of aflatoxins into embryonated eggs is a concern for
poultry producers, because many studies with in ovo AFB1 injections confirmed the
risk of AFB1 exposure to embryos. For example, in ovo exposure of chickens and
turkeys to AFB1 caused DNA damage in the embryonic liver and increased embryo
mortality (Dietert et al., 1985; Edrington et al., 1995; Celik et al., 2000; Sur et al.,
2003; Williams et al., 2011; Oznurlu et al., 2012). When laying hens were fed with
AFB1 contaminated feed to simulate the natural route of embryonic exposure, AFB1
caused reduced hatchability (Howarth et al., 1976; Qureshi et al., 1998; Khan et al.,
2014) and compromised cellular and humoral immune functions post hatch (Sur et al.,
2011; UI-Hassan et al., 2012). Embryonic AFB1 exposure can lead to morphological
defects (Edrington et al., 1995) such as abnormal area opaca cells (Celik et al., 2000;
Sur et al., 2003), skeletal defects in the tibia growth plate (Oznurlu et al., 2012), and
inhibition of bursal follicle development (Celik et al., 2000; Sur et al., 2003), which
can consequently reduce embryo viability and adversely affect hatched progeny. In
addition, embryonic exposure of AFB1 causes immunosuppression, thereby
increasing the incidence of infectious disease in young poultry and detrimentally
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affecting their health and productivity.
5.

Strategies to control aflatoxins
Because of the recognition of aflatoxin as a potent human carcinogen, federal

regulation of allowable amounts of the toxin in food and feed is nearly universal. The
Food and Drug Administration (FDA) in the United States regulates the amount of
allowable aflatoxin contamination as 20 ppb in crops or 0.5 ppb in milk for humans.
In Europe, foods containing more than 2 ppb of AFB1 or 4 ppb of aflatoxins are
rejected, whereas the limit of aflatoxin contamination is 30 ppb in India (Van Egmond
and Jonker, 2005).
Extensive studies have been conducted for controlling aflatoxin contamination
(Goldblatt, 1969, 1971; Pons and Goldblatt 1969; Pons 1976) since the discovery of
this toxin. In principle, there are three possible ways to avoid harmful effects caused
by aflatoxin: (1) prevention of aflatoxin producing fungi at pre-harvest stage; (2)
detoxification of aflatoxin-contaminated food and agricultural commodities at postharvest level; (3) inhibition of absorption of aflatoxin from consumed food in the
digestive tract to reduce aflatoxicosis
5.1 Pre-harvest control strategies
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One strategy to control aflatoxin contamination at the pre-harvest level is based
on the identification of crop lines resistant to insects or harsh environmental
conditions such as drought, because insects and drought stress damage crops, thereby
favoring aflatoxin contamination (Campbell et al., 1995; Campbell et al., 1997; Lynch
et al., 2003; Cotty and Jaime-Garcia, 2007). Several researchers have focused on
identifying fungus-related and aflatoxin-resistant genes and proteins that are
important for defense against A. flavus invasion and/or aflatoxin bio-synthesis (Huang
et al., 1997; Chen et al., 2006; Guo et al., 2006; Chen et al., 2010). Therefore, genetic
modifications of crops such as corn, cottonseed, and peanut may gain resistance to
aflatoxin contamination by being transferred with the genes that are responsible for
aflatoxin inhibition enzymes (Cary et al., 2000, Mishra and Das, 2003). In addition,
control of aflatoxin can also be achieved by targeting mechanisms governing aflatoxin
bio-synthesis with the identification of genes and enzymes responsible for aflatoxin
synthesis (Yu et al., 2000; Chang et al., 2000). Moreover, many organisms such as
bacteria, molds, and algae can degrade or reduce aflatoxin (Mishra and Das, 2003).
For example, utilization of non-aflatoxigenic A. flavus strains (or called atoxigenic
strains; strains that cannot produce aflatoxin) as a bio-control agent to inhibit the
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growth of aflatoxigenic A. flavus in the field has been investigated. Mechanism of this
bio-control is through competitive exclusion or inhibition of toxigenic A. flavus by
non-toxigenic strains for nutrient substrates (Cleveland et al., 2003; Pitt and Hocking,
2006). Large-scale development of atoxigenic strains has been undertaken since 1998
by the Arizona cotton industry (Antilla and Cotty, 2001). To ensure the effectiveness
of atoxigenic A. flavus strains to control aflatoxin contamination on crops, they must
be applied at a time and in a manner that allows successful competition with
aflatoxin-producers (Cotty et al., 1994). This means atoxigenic strains should be
applied when the aflatoxin concentrations on the crops are still comparatively low
(Cotty et al., 1994; Cotty, 1997). Two biological control agents using non-toxigenic A.
flavus strains registered by the U.S. Environmental Protection Agency are currently
commercially available. Afla-Guard is one of the agents that is composed of hulled
barley coated with conidia of non-toxigenic A. flavus strain NRRL21882, which is
registered for use on peanuts and corn (Dorner, 2010). The other bio-control agent is
A. flavus AF36, primarily used for reducing aflatoxin on cottonseed. Here, A. flavus
strain NRRL21882 lacks the aflatoxin bio-synthesis cluster from hexA to the
telomeric region, and AF36 is defective in the aflatoxin polyketide gene pksA. Thus,
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both stains are not able to produce aflatoxins (Ehrlich and Cotty, 2004). Similarly,
small-scale experiments have also been conducted on competitive exclusion using
Bacillus thuringiensis, the bacterium that produces Bacillus thuringiensis toxins (BT).
Bacillus thuringiensis has not only been assessed for biological control properties
against insects for decades, but also been studied for its antifungal effects on fungal
colonization and mycotoxin contamination (Zhakharian et al., 1979). However, results
were not consistent in terms of the efficacy on transgenic BT corn in reducing
aflatoxin contamination. For example, Abbas et al. (2008) documented that aflatoxin
contamination has been reduced in BT corn when compared with a non-BT line,
whereas Buntin et al. showed no significant differences between non-BT and BT corn
(Buntin et al., 2001). Scientific reports have indicated that tremendous reduction of
aflatoxin levels in BT maize can occur when high levels of insect resistance are
available (Cleveland et al., 2003).
5.2 Post-harvest control strategies
After harvest, crops can still be contaminated by aflatoxin-producing fungus and
aflatoxin, if the crops are improperly treated during drying process, and stored under
poor conditions such as excessive heat and moisture, and exposure to insects and
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other pests (Hell et al. 2000). Hence, controlling aflatoxin in post-harvest settings is
crucial. For a detoxification method to be acceptable, it must be efficient, safe and
cost effective while safeguarding nutritional quality (Hell et al., 2008). There are
several physical methods for detoxification of aflatoxin at post-harvest level such as
prolonged heating with pressure; however, certain nutrients could be destroyed during
the process. In addition, a variety of chemicals have also been screened for their
ability to react with aflatoxins such as methanol, oxidizing agents, and ammonia
(Samarajeewa et al., 1990). Some mycotoxins can be destroyed chemically with
calcium hydroxide, monoethylamine, ozone or ammonia, where ammoniation
degrades 95-98% of the aflatoxin. However, public health safety concerns of chemical
residues have limited their applicability in foods.
Another post-harvest intervention is to use microorganisms for degradation of
aflatoxin in food or animal feed. Karunaratne (1990) indicated that Lactobacillus
acidophilus, Lactobacillus bulgaricus, and Lactobacillus planatarum could be used to
inhibit the growth of the aflatoxin-producing molds and degrade aflatoxin.
Bifidobacterium is also reported to bind to AFB1 efficiently to reduce aflatoxin
(Peltonen et al., 2000). However, using probiotic bacteria to reduce aflatoxin
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contamination also has its disadvantages since these microorganisms would not only
utilize the food for their growth, but may themselves release undesirable compounds
such as organic acids.
Several interventions have been developed to control aflatoxin contamination in
feed to reduce aflatoxicosis in animals and subsequent transfer of aflatoxin residues
from food-producing animals to humans. To minimize the considerable economic
losses caused by aflatoxin contaminated crops (Henry et al., 1999), various nonnutritive adsorbents have been employed for reducing or inactivating aflatoxin in
feeds. For instance, supplementation of a toxin binder such as clay in the feed is one
of the widely used approaches to control aflatoxin in the feed industry. The clay
selectively binds tightly to aflatoxins to prevent their absorption in the gastrointestinal
tracts and the clay-aflatoxin complex is eliminated from the body (Hell et al., 2008).
Evidence suggests that aflatoxins may react at multiple sites on the clay particle,
especially interlayer regions, edges, and basal surfaces (Mishra and Das, 2003).
Hydrated sodium calcium aluminosilicates (HSCAS) is another toxin binder, which
reduces aflatoxin absorption by binding with the β-carbonyl portion of aflatoxin
molecules, thereby effectively reducing aflatoxicosis (Scheideler, 1993; Ledoux et al.,
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1999). Hydrated sodium calcium aluminosilicates (HSCAS) have also been
demonstrated to act as an aflatoxin enterosorbent that tightly and selectively binds the
toxin in the gastrointestinal tract of animals, thus decreasing their bioavailability and
consequently alleviating aflatoxicosis (Scheideler, 1993; Phillips, 1999). Such
adsorbents act more as prophylactics than curative remedies. However, there may be
certain risk factors for their inclusion in diet before proper testing, since several
adsorbents have been shown to impair nutrient utilization (Kubena et al., 1993) and
mineral absorption in animals (Edrington et al., 1997).
6.

Phytochemicals
Plant-derived essential oils are a group of natural and environmentally friendly

antimicrobials that have traditionally been used as food preservatives and flavor
enhancers (Pitasawat et al., 2007; Upadhyay et al., 2014). A great majority of these
compounds are secondary metabolites, and are produced as a result of reciprocal
interactions between plants, microbes, and animals (Reichling, 2010). These
secondary metabolites could be species or genera specific in their action, and do not
primarily contribute to major metabolic processes in plants, but potentiate their ability
to survive local environments (Harborne, 1993) and defend plants against
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microorganisms such as bacteria, fungi and viruses (Kennedy and Wightman, 2011).
In the past decade, the use of plant-derived compounds has gained significant
attention due to increasing concerns over the safety of synthetic chemicals and the
emergence of antibiotic-resistant strains of microorganisms (Salamci et al., 2007). The
antifungal and antitoxigenic properties of several plant oils have been identified (Burt
et al, 2004). The plant-derived antimicrobials investigated for controlling aflatoxicosis
in this Ph.D. dissertation research were carvacrol (CR) and trans-cinnamaldehyde
(TC).
6.1 Carvacrol
Carvacrol (CR), listed as generally recognized as safe (GRAS) by the FDA, is a
major component in oregano oil obtained from Origanum vulgare (Lamiaceae), a
common herb found in Europe and the Mediterranean. Oregano oil has been found
effective against bacterial and fungal infections of the gastrointestinal and
genitourinary tract (Blumenthal et al., 2000; Adam et al., 2004; Chun et al., 2005) as
well as against a wide range of bacterial pathogens, including Staphylococcus aureus,
Escherichia coli, and Streptococcus pneumoniae (Hersch-Martinez et al., 2005). In
addition, oregano oil was found to inhibit the growth of Fusarium proliferatum and
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fumonisin B1 production in maize (Velluti et al., 2003).
6.2 Trans-cinnamaldehyde
Trans-cinnamaldehyde (TC) is another GRAS-status ingredient present in the
bark extract of cinnamon (Cinnamomum zeylandicum). Various studies have
demonstrated the antimicrobial properties of TC against both gram-negative and positive bacteria (Burt, 2004; Gill and Holley, 2006; Upadhyay et al., 2014). Previous
research from our laboratory found that TC was effective in inhibiting biofilm
formation and inactivating mature biofilms of Cronobacter sakazakii (Amalaradjou
and Venkitanarayanan, 2011) and uropathogenic Escherichia coli (Amalaradjou et al.,
2010). Additionally, our laboratory investigated the efficacy of TC in reducing
Salmonella Enteritidis colonization in chickens (Kollanoor-Johny et al., 2012). The
results from this study showed that in-feed supplementation of TC to chickens did not
adversely affect the chicken’s performance and feed palatability (Kollanoor-Johny et
al., 2012).
In summary, aflatoxins are fungal toxic metabolites of A. flavus and A.
parasiticus, which can frequently contaminate a variety of feed ingredients.
Contamination of poultry feed with aflatoxins is a major concern to both feed and

33

poultry industry due to their deleterious effects in chickens such as reduced chicken
performance and increased mortality. In addition, aflatoxins are regulated by FDA due
to their carcinogenic and hepatotoxic effects, and their presence as residues in chicken
meat and egg. Therefore, it is critical to develop scientifically validated strategies for
controlling aflatoxin in poultry feed and attenuate aflatoxicosis in chickens.
Based on published literature and preliminary research, this Ph.D. dissertation
hypothesizes that CR and TC reduce A. flavus and A. parasiticus growth and aflatoxin
production. Moreover, in-feed supplementation of CR and TC reduces aflatoxicosis in
chickens. The specific objectives were:
1.

To study the effect of CR and TC on A. flavus and A. parasiticus growth,
AF production, and expression of toxin synthesis genes in a broth system
and in chicken feed during long-term storage.

2.

To determine the efficacy of CR and TC in reducing aflatoxin-induced
toxicity on chicken embryos.

3.

To study the efficacy of in-feed supplementation of CR and TC in
reducing aflatoxicosis in chickens.

4.

To investigate the effect of in-feed supplementation of CR and TC on the
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hepatic transcriptome of chicken exposed to aflatoxins.
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ABSTRACT

Aflatoxins (AF) are toxic metabolites primarily produced by molds, Aspergillus flavus
and Aspergillus parasiticus. Contamination of poultry feed with AF is a major
concern to the poultry industry due to severe economic losses stemming from poor
performance, reduced egg production and diminished egg hatchability. This study
investigated the inhibitory effect of two generally regarded as safe (GRAS), natural
plant compounds, namely carvacrol (CR) and trans-cinnamaldehyde (TC), on A.
flavus and A. parasiticus growth and AF production in potato dextrose broth (PDB)
and in poultry feed. In broth culture, PDB supplemented with CR (0%, 0.02%, 0.04%
and 0.08%) or TC (0%, 0.005%, 0.01% and 0.02%) was inoculated with A. flavus or
A. parasiticus (6 log CFU/mL), and mold counts and AF production were determined
on days 0, 1, 3, and 5. Similarly, 200 g portions of poultry feed supplemented with CR
or TC (0%, 0.4%, 0.8%, and 1.0%) were inoculated with each mold, and their counts
and AF concentrations in the feed were determined at 0, 1, 2, 3, 4, 8, and 12 weeks of
storage. Moreover, the effect of CR and TC on the expression of AF synthesis genes
in A. flavus and A. parasiticus (aflC, nor1, norA, and ver1) was determined using realtime quantitative PCR (RT-qPCR). All experiments had duplicate samples and were
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replicated three times. Results indicated that CR and TC reduced A. flavus and A.
parasiticus growth and AF production in broth culture and chicken feed (P < 0.05).
All tested concentrations of CR and TC decreased AF production in broth culture and
chicken feed by at least 60% when compared to controls (P < 0.05). In addition, CR
and TC down-regulated the expression of major genes associated with AF synthesis in
the molds (P < 0.05). Results suggest the potential use of CR and TC as feed additives
to control AF contamination in poultry feed.
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1. Introduction
Aflatoxins (AF) are a group of toxic metabolites of Aspergillus flavus and
Aspergillus parasiticus. AF contaminate a variety of feed ingredients, including
peanuts, corn and cottonseed (Oguz et al., 2000; Sur and Celik, 2003). Although at
least 18 types of AF have been identified, only four types, namely AFB1, B2, G1, and
G2, are commonly found in the feed (Leeson et al., 1995). Aflatoxin B1, listed as
group I human carcinogen by the International Agency for Research on Cancer, is
considered the most toxic (Yunus et al., 2011).
Contamination of poultry feed with AF is a major concern to the poultry industry
since aflatoxicosis in chickens results in significant economic losses due to poor feed
utilization, decreased body weight gain, reduced egg production and increased
mortality (Qureshi et al., 1998; Tessari et al., 2006; Oguz, 2011). The negative effects
of AF in poultry have been widely investigated (Giambrone et al., 1978; Celik et al.,
1996; Sur and Celik, 2003). AF ingested by chickens can accumulate in most of the
soft tissues and fat depots resulting in hemorrhagic and fatty liver syndrome (Leeson
et al., 1995; Bintvihok et al, 2002). In addition, AF residues found in poultry meat and
eggs (Jacobson and Wiseman, 1974; Sudhakar, 1992; Qureshi et al, 1998) pose a
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significant health hazard to humans due to their carcinogenic, teratogenic, and
mutagenic properties (Ross et al., 1992; Bintvihok et al., 2002). Thus it is critical to
control aflatoxins in poultry feed to protect public health, bird health, and ensure the
economic viability of the poultry industry. Moreover, in light of the risks associated
with aflatoxicosis in chicken, the U.S. Food and Drug Administration (USFDA) has
established guidelines for the maximum total AF level permitted in poultry feed,
which is 20 ppb in corn and peanut products for chicks, and 100 ppb in feed for adult
chickens (FDA, 2009).
The economic loss due to mycotoxin contamination of crops and the cost of
research and monitoring activities to control mycotoxins are estimated to range
between $500 million and $1.5 billion a year (Abarca et al., 1994; Robens and
Cardwell, 2003). However, cost-effective and practical methods to prevent AF
contamination in poultry feed are currently limited. At present, the inclusion of AFbinding adsorbent in feed is employed to protect birds from the harmful effects of AF.
However, several adsorbents have been shown to impair nutrient utilization (Chung et
al., 1990; Kubena et al., 1993; Scheideler et al., 1993) and mineral absorption in
chickens (Chestnut et al., 1992; Edrington et al., 1997). It was concluded that none of
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the current strategies to control AF are sufficient to completely fulfill the necessary
safety and cost requirements (Teniola et al., 2005). This highlights the need for an
effective strategy to control AF contamination in poultry feed.
Plant-derived essential oils are a group of natural, environmentally friendly
antimicrobials that have traditionally been used as food preservatives and flavor
enhancers. In the past decade, the use of plant-derived compounds has gained
significant attention due to increasing concern over the safety of synthetic chemicals
and emergence of antibiotic-resistant strains of microorganisms (Salamci et al., 2007).
The antifungal and antitoxigenic properties of several plant oils have been identified
(Burt et al, 2004). Carvacrol (CR) is a major ingredient in oregano oil (Origanum
glandulosum), whereas trans-cinnamaldehyde (TC) is a principal component in
cinnamon bark (Cinnamomum zeylandicum). Both these compounds are classified as
generally recognized as safe (GRAS) for addition in food products by the FDA
(Adams et al., 2004; Higueras et al., 2013). This study investigated the efficacy of CR
and TC in reducing A. flavus and A. parasiticus growth and AF production in potato
dextrose broth (PDB), and poultry feed during long–term storage. In addition, the
effect of aforementioned plant-derived antimicrobials on A. flavus and A. parasiticus
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toxin production genes was studied using real-time quantitative PCR (RT-PCR).
2. Materials and Methods
2.1 A. flavus and A. parasiticus inoculum preparation
Aspergillus flavus NRRL 3357 (A. flavus-3357) and A. parasiticus NRRL 4123
(A. parasiticus-4123) obtained from USDA-ARS (NRRL) culture collection, Peoria,
IL were used in this study. These mold isolates were tested for purity, and identified
by growth on Aspergillus differentiation agar (ADA; catalogue no. 17121, SigmaAldrich, St. Louis, MO). Aspergillus flavus and A. parasiticus were subcultured on
potato dextrose agar (PDA; catalogue no. P6685, Sigma-Aldrich, St. Louis, MO) and
incubated at 25oC for 5 days. Each inoculum was harvested by adding sterile water to
the PDA slants to get the final mold concentration of 6 log CFU/mL (Farag et al.,
1989).
2.2 Effect of CR and TC on mold growth and AF production in broth
The effect of CR and TC on growth and AF production by A. flavus and A.
parasiticus was studied in potato dextrose broth (PDB), as described by Farag et al.
(1989). Briefly, 10 mL of PDB was inoculated with A. flavus or A. parasiticus (6 log
CFU/mL), followed by the addition of CR (catalogue no. W224502, Sigma-Aldrich,
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St. Louis, MO) or TC (catalogue no. W228605, Sigma-Aldrich, St. Louis, MO). The
final CR and TC concentrations in PDB were 0.02%, 0.04%, and 0.08%, and 0.005%,
0.01%, and 0.02%, respectively. These concentrations were selected from preliminary
experiments that screened the antifungal and antitoxin effect of a wide range of these
compounds against several strains of A. flavus and A. parasiticus. Potato dextrose
broth devoid of CR or TC served as the control. The inoculated broth supplemented
with or without CR or TC was incubated at 25°C for 5 days. On days 0, 1, 3, and 5,
the mold counts were enumerated on PDA plates following serial dilution in
phosphate buffered saline (PBS, pH 7.0), and AF concentrations in the supernatant
were determined using a commercial ELISA kit (AgraQuant total Aflatoxin, catalogue
no. CAKAQ 1100, Romer Labs, Union, MO) (Salem and Ahmad, 2010).
2.3 Effect of CR and TC on mold growth and AF production in feed
Layer-grower crumble feed free of any toxin binder was procured from
University of Connecticut poultry farm. Prior to use, representative samples from the
experimental feed were analyzed for A. flavus, A. parasiticus and AF concentration to
ensure that there was no detectable AF contamination. The feed was inoculated with
each mold separately using the method described by Kusumaningtyas et al. (2006),
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wherein A. flavus-3357 or A. parasiticus-4123 was added to 200 g portions of feed to
obtain ~5 log CFU/g, and mixed well. After inoculation, the feed was added with CR
or TC at 0%, 0.4%, 0.8% or 1.0% followed by incubation at 25oC for 3 months. A
twenty-gram portion of the feed was sampled on weeks 0, 1, 2, 3, 4, 8 and 12, of
which 10 g for mold enumeration and 10 g for AF detection were used.
2.4 Determination of mold counts and aflatoxins in feed
To enumerate A. flavus and A. parasiticus in the control and treated feed, 10 g
portions of feed samples were added to 40 mL of PBS in sterile whirl-pak bags
(catalogue no. Z527017, Sigma-Aldrich, St. Louis, MO), and pummeled in a
stomacher (Stomacher 400 Circulator, Seward, Davie, FL) for 1 min. The feed
homogenate was serially diluted (1:10) in PBS, and 0.1 mL aliquots from appropriate
dilutions were surface plated on duplicate PDA plates, and incubated as before.
The concentration of AF in the feed was quantitated using the aforementioned
commercial ELISA kit (AgraQuant total Aflatoxin, catalogue no. CAKAQ 1100,
Romer Labs, Union, MO). To prepare AF extracts, 10 g portions of feed were mixed
with 40 mL of 70% methanol (70/30 methanol/water) (v/v) for sample extraction. One
hundred μL of the sample extract was mixed with 200 μL of conjugate solution
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provided in the kit. Following mixing, 100 μL of the solution was transferred to
antibody-coated well and incubated for 15 min. After incubation, the content of each
well was discarded, and the wells were washed five times with distilled deionized
water. Any excess water was discarded and the wells were dried. One hundred
microliters of the substrate solution were then added to each well, incubated for 5 min,
and the reaction was stopped by adding 100 μL of stop solution. The optical density
of the sample at 450 nm from each well was read in a spectrophotometer (Gen5
spectrophotometer, Biotek, Winooski, VT). The total AF concentration was calculated
by extrapolating the optical density from a calibration standard curve prepared with a
wide range of AF concentrations (Zheng et al., 2005). The results were expressed in
parts per billion (ppb).
2.5 RNA isolation and RT-qPCR
The effect of CR and TC on the expression of A. flavus and A. parasiticus AF
synthesis genes (aflC, nor1, norA, and ver1) was determined using RT-qPCR (Cuero
et al., 2003). A. flavus or A. parasiticus was grown with or without the SIC (subinhibitory concentration, the highest concentration that did not decrease mold growth)
of CR (0.02%) and TC (0.005%) in 10 mL of PDB at 25oC for 5 days. Total RNA was
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extracted from each sample using RNeasy Plant Mini RNA Kit (catalogue no. 74903,
Qiagen, Valencia, CA). The RNA was quantified by measuring the absorbance at 260
and 280 nm using a Nanodrop (Bio-Rad, Hercules, CA). Complementary DNA
(cDNA) was synthesized using the Superscript II Reverse transcriptase kit (catalogue
no. 18064-014, Life technology, Grand Island, NY), and RT-qPCR was performed
with specific primers (Table 1) for aflC, nor1, norA, ver1, and β-tublin (endogenous
control). Relative gene expression was determined by comparative critical threshold
(Ct) method using a 7500 Fast Real-Time PCR system (Applied Biosystems). Data
were normalized to the β-tublin and the level of candidate gene expression between
treated and control samples was determined.

2.6 Statistical analysis
Data from broth, poultry feed, and gene expression studies were analyzed
separately. All studies were repeated three times with duplicate samples for each
treatment and control. A repeated measures design with a factorial treatment structure
was used in broth (2 x 4 x 4) and feed study (2 x 4 x 7). In broth study, the factors
were 2 plant compounds (CR and TC), 4 treatment concentrations (CR at 0.01%,
0.04%, and 0.08%; TC at 0.005%, 0.01%, and 0.02%) and 4 time points (day 0, 1, 3,
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and 5 days). In the feed study, the factors were 2 plant compounds (CR and TC), 4
treatment concentrations (CR or TC 0%, 0.4%, 0.8% and 1.0%) and 7 time points
(week 0, 1, 2, 3, 4, 8 and 12 weeks). The data were analyzed using the PROC MIXED
procedure of Statistical Analysis Software (SAS, version 9.3, SAS institute, Inc., Cary,
NC, USA). The differences among the means were detected at P < 0.05 using Fisher’s
least significance test (LSD). In the gene expression study, the differences between
independent treatments were analyzed using two tailed t-test, and considered
significant when P < 0.05.
3. Results
3.1 Effect of CR and TC on mold growth and AF production in broth
Figure 1 shows the effect of CR (0%, 0.02%, 0.04% and 0.08%) and TC (0%,
0.005%, 0.01% and 0.02%) on A. flavus and A. parasiticus growth and AF production
in PDB.

On day 0, approximately 4 to 4.5 log CFU/mL of mold counts were

recovered from treated and control samples (Fig 1A and 1B). Although the mold
counts between control and the lower concentrations of CR (0.02% and 0.04%) were
not different throughout the incubation period (P > 0.05), CR at 0.08% completely
inhibited the growth of both molds from day 1 through day 5. In contrast to this, all
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tested CR concentrations reduced AF production by both mold species by more than
95% when compared to control samples (Fig. 1C and 1D). Trans-cinnamaldehyde
exerted a similar inhibitory effect on A. flavus and A. parasiticus growth and AF
production (Fig 2). Although A. flavus and A. parasiticus growth was markedly
inhibited by only the highest concentration of TC (0.2%) (Fig. 2 A and 2 B), AF
synthesis by both molds was decreased by more than 90% at all tested TC
concentrations (Fig. 2C and 2D).
3.2 Effect of CR and TC on mold growth and AF production in feed
Carvacrol and TC exhibited a similar inhibitory effect on A. flavus and A.
parasiticus growth and AF production in poultry feed. For example, the growth of
both molds was significantly decreased by 0.8 and 1.0% CR from weeks 4 through 12,
with 4.0 log and 3 log CFU/mL reductions in A. flavus and A. parasiticus populations,
respectively at the end of the storage period (Fig. 3A and 3B). However, irrespective
of the concentration, CR (0.4%, 0.8%, and 1.0%) decreased AF production by both
molds by more than 60% at 12 weeks compared to control (P < 0.05) (Figure 3C and
3D). Figure 4 shows the inhibitory effect of TC on A. flavus and A. parasiticus growth
and AF production in feed, where it can be seen that TC (0.8% and 1.0%) reduced the
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counts of both molds throughout the storage period (P < 0.05) (Fig. 4 A and 4B).
Similar to CR, all concentrations of TC inhibited AF production by approximately
60% by the end of storage period (P < 0.05) (Fig. 4 C and 4D).
3.3 Effect of CR and TC on the expression of AF production genes
The effect of CR and TC on the expression of AF synthesis genes in A. flavus
and A. parasiticus is presented in Fig. 5. Real-time quantitative PCR results revealed
that the SIC of CR (0.02%) and TC (0.005%) down-regulated (P < 0.05) the
expression of the majority of genes critical for AF synthesis in A. flavus and A.
parasiticus (aflC, nor1, and norA) (P < 0.05). Compared to untreated controls, CR
down-regulated the expression of nor1 and norA in A. flavus and A. parasiticus by >
10 fold (Fig. 5 A and 5B), whereas TC reduced the expression of these genes by more
than 4 fold (P < 0.05) (Fig. 5C and 5D).
4.. Discussion
Aflatoxicosis in chickens is a serious problem affecting bird health, performance,
and egg hatchability. In addition, the negative effects on public health due to the
consumption of AF-contaminated poultry products constitute a significant hazard.
Therefore, the development of practical and effective methods to control AF
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contamination in feed is critical for the sustainability of the poultry industry. In this
regard, a viable approach would be to prevent or minimize AF production by molds in
poultry feed (Miedaner and Reinbrecht, 1999).
This study investigated the efficacy of CR and TC, two naturally occurring and
GRAS-status plant compounds in inhibiting A. flavus and A. parasiticus growth and
AF production. Although both plant compounds were effective in reducing AF
production by A. flavus and A. parasiticus, no consequential association between the
mold growth and AF production was observed. For example, although all tested CR
concentrations inhibited AF production in PDB by greater 95%, only 0.08% of the
compound was effective in significantly inhibiting mold growth (Fig. 1). Likewise,
AF production was decreased by all tested concentrations of TC although mold
growth was significantly inhibited only by 0.01 and 0.02% of the compound (Fig. 2).
Similar results were also observed when the compounds were tested in poultry feed
(Fig. 3 and Fig. 4). These findings concur with the study by Kusumaningtyas et al.
(2006), who reported no correlation between the growth of A. flavus and AF
production. Similarly, Bluma and Etchaverry (2006) reported that when A. flavus was
grown in maize in the presence of Bacillus strains, the reduction in mold counts was
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less than 30%, but levels of detectable AFB1 were significantly reduced.
Since the results indicated that CR and TC decreased AF levels in the broth and
feed substantially even with no or minimal inhibition on mold growth, we
hypothesized that the reduction in AF synthesis may be due to any potential inhibitory
effect of CR and TC on the genes involved in AF production in A. flavus and A.
parasiticus. To test this, we analyzed the expression of critical AF synthesis genes in
A. flavus and A. parasiticus treated with and without the SIC of CR or TC. Since the
SICs of antimicrobials, including antibiotics can modulate microbial physicochemical functions, including that of genes, they are used for studying the effect of
antimicrobials on gene expression and virulence in microorganisms (Goh et al. 2002;
Fonesca et al., 2004; Tsui et al. 2004). The RT-qPCR data on gene expression revealed
that both CR and TC significantly down-regulated the transcription of aflC, nor1, and
norA, which are involved with AF synthesis in A. flavus and A. parasiticus (Fig. 5).
In the AF biosynthesis pathway, aflC is involved in the conversion of acetate to
norsolorinic acid (NOR), which is the first stable AF synthesis intermediate, whereas
nor1 and norA are involved in the conversion of NOR to averatin (AVN), which
subsequently undergoes several reactions in the pathway for AF synthesis (Yu et al.,
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2004; Ehrlish et al., 2005).
Previous studies from our laboratory showed that plant compounds such as TC
could be used as feed ingredients to reduce the colonization of Salmonella Enteritidis
in chickens, without deleteriously affecting feed intake and body weight of birds
(Kollanoor-Johny et al., 2012). Similarly, Arsi and coworkers (2011) observed that infeed supplementation of CR reduced Campylobacter jejuni carriage in broiler
chickens. These findings suggest that CR and TC, especially due to their lipophilic
nature, can be easily mixed with other feed ingredients in a poultry ration. The cost of
TC is ~ $2/lb, whereas CR is reported to cost ~ $22/lb (Darre et al., 2014). However,
the cost of these chemicals in bulk quantities is expected to be lower. Therefore, CR
and TC could practically be used as ingredients in poultry feed to control aflatoxicosis,
especially in light of the observed anti-toxigenic effect at concentrations as low as
0.4% in the feed (Fig. 3 and Fig. 4).
In conclusion, this study demonstrated that CR and TC significantly inhibited A.
flavus and A. parasiticus growth and AF production in broth and poultry feed (P <
0.05). In addition, CR and TC down-regulated critical AF synthesis genes (aflC, nor1,
norA, and ver1) in A. flavus and A. parasiticus. Our future studies will validate the
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efficacy of the aforementioned plant compounds as feed additives in reducing
aflatoxicosis in chickens.
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Table 1. List of primers used for real-time quantitative PCR (RT-qPCR).

Gene

Accession
number

Gene Function

JF418554.1

Polyketide
synthase

EF565463.1

Reductase

AB618249.1

NOR3 Reductase/
dehydrogenase

AY987856.2

Dehygrogenase/
ketoreductase

JF740161.1

Endogenous
control

aflCF1
aflCR2

Sequence (5’-3’)
5’ TGCATGGCGATGTGGTAGTT 3’
5’ GTAAGGCCGCGAGAGAAAG 3’
5’ GGCAACCCGCCTGATG-3’

nor1F
nor1R
norAF
norAR
ver1F
ver1R
ß-tublinF
ß-tublinR
1

5’ GGCGCCGATCAAGACAAA 3’
5’-TCTAGCGCCGGTGTTCGT 3’
5’-TTACCCCTTTCCAGCCATTG 3’
5’ GCGGAGAAGGTAGTTCAACAGATC 3’
5’ GACATCGGCCTGGATTGC 3’
5’ CGTGTCGGCGACCAGTTC 3’
5’ CCTCACCAGTGTACCAATGCA 3’

F: Forward primer; 2R: Reverse primer; 3NOR: norsolorinic acid.
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Figure 1. Effect of carvacrol (CR) at 0.02%, 0.04%, and 0.08% on Aspergillus flavus
NRRL 3357 and Aspergillus parasiticus NRRL 4123 growth and aflatoxin production
in broth. Data are the mean ± SEM obtained from 3 separate experiments with
duplicate samples on each sampling point (0, 1, 3, and 5 day). Error bar indicates
SEM (n=6). Fig. 1A and 1B show the growth of A. flavus and A. parasiticus, whereas
Fig. 1C and 1D show AF production by the molds.
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Figure 2. Effect of trans-cinnamaldehyde (TC) at 0.005, 0.01, and 0.02% on
Aspergillus flavus NRRL 3357 and Aspergillus parasiticus NRRL 4123 growth and
aflatoxin production in broth. Data are the mean ± SEM obtained from 3 separate
experiments with duplicate samples on each sampling point (0, 1, 3, and 5 day). Error
bar indicates SEM (n=6). Fig. 2A and 2B show the growth of A. flavus and A.
parasiticus, respectively, whereas Fig. 2C and 2D show AF production by the molds.
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Figure 3. Effect of Carvacrol (CR) at 0.4, 0.8, and 1.0% on Aspergillus flavus NRRL
3357 and Aspergillus parasiticus NRRL 4123 growth and aflatoxin production in
poultry feed. Data are the mean ± SEM obtained from 3 separate experiments with
duplicate samples on each sampling point (0, 1, 2, 3, 4, 8, 12 week). Error bar
indicates SEM (n=6). Fig. 3A and 3B show the growth of A. flavus and A. parasiticus,
respectively, whereas Fig. 3C and 3D show AF production by the molds.
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Fig 4. Effect of trans-cinnamaldehyde (TC) at 0.4, 0.8, and 1.0% on Aspergillus
flavus NRRL 3357 and Aspergillus parasiticus NRRL 4123 growth and aflatoxin
production in poultry feed. Data are the mean ± SEM obtained from 3 separate
experiments with duplicate samples on each sampling time point (0, 1, 2, 3, 4, 8, 12
week). Error bar indicates SEM (n=6). Fig. 4A and 4B show the growth of A. flavus
and A. parasiticus, respectively, whereas Fig. 4C and 4D show AF production by the
molds.
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Figure 5. Effect of SIC of carvacrol (CR) (0.02%) and trans-cinnamaldehyde (TC)
(0.005%) on the expression of aflatoxin synthesis genes in Aspergillus flavus NRRL
3357 and Aspergillus parasiticus NRRL 4123. Data are the mean ± SEM obtained
from 6 replicate samples. Error bar indicate SEM (n=6). Fig. 5A and 5B show the
effect of CR on AF synthesis gene expression in A. flavus and A. parasiticus. Fig. 5C
and 5D show the effect of TC on AF synthesis gene expression in A. flavus and A.
parasiticus, respectively.
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Chapter IV
Phytochemicals reduce aflatoxin-induced toxicity in chicken embryos
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ABSTRACT
Aflatoxins (AF) are toxic metabolites produced by molds, Aspergillus flavus and
Aspergillus parasiticus, which frequently contaminate poultry feed ingredients.
Ingestion of AF-contaminated feed by chickens leads to deleterious effects, including
decreased bird performance and reduced egg production. Moreover, AF residues in
fertilized eggs result in huge economic losses by decreasing embryo viability and
hatchability. This study investigated the efficacy of two generally recognized as safe
phytochemicals, namely carvacrol (CR) and trans-cinnamaldehyde (TC), in protecting
chicken embryos from AF-induced toxicity. Day-old embryonated eggs were injected
with 50 ng or 75 ng AF with or without 0.1% CR or TC, followed by incubation in a
hatching incubator for 18 days. Relative embryo weight, yolk sac weight, tibia weight,
tibia length, and mortality were recorded on day 18 of incubation. The effect of
phytochemicals and methanol (diluent) on embryo viability was also determined.
Each experiment had ten treatments with 15 eggs/treatment (n=150 eggs/experiment)
and each experiment was replicated three times. Both phytochemicals significantly
decreased AF-induced toxicity in chicken embryos. At 75 ng of AF/egg, CR and TC
increased the survival of chicken embryo by ~ 55%. Moreover, CR and TC increased
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relative embryo weight by ~ 3.3% and 17% when compared to eggs injected with 50
ng or 75 ng AF, respectively. The growth of embryos (tibia length and weight) was
improved in phytochemical-treated embryos compared to those injected with AF
alone (p<0.05). Phytochemical and methanol treatments did not adversely affect
embryo survival, and other measured parameters (p>0.05). Results from this study
demonstrate that CR and TC could reduce AF-induced toxicity in chicken embryos;
however, additional studies are warranted to delineate the mechanistic basis behind
this effect.
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1. Introduction
Aflatoxins (AF) are a group of toxic metabolites of Aspergillus flavus and
Aspergillus parasiticus, which can frequently contaminate a variety of feed
ingredients, including peanuts, corn and cottonseed (Oguz et al., 2000; Sur and Celik,
2003). Among the four types of AF identified in feed, Aflatoxin B1 (AFB1) is one of
the most potent hepatocarcinogens, and has been listed as a group I human carcinogen
by the International Agency for Research on Cancer (Yunus et al., 2011).
Contamination of poultry feed with AF is a major concern to the poultry industry,
since aflatoxicosis in chickens results in significant economic losses due to poor feed
utilization, decreased body weight gain, reduced egg production and increased
mortality (Qureshi et al., 1998; Tessari et al., 2006; Oguz, 2011). Once ingested by
chickens, AF can accumulate in most of the soft tissues and fat depots of the chicken,
and cause hemorrhagic and enlarged liver (Leeson et al., 1995; Bintvihok et al, 2002).
Furthermore, during egg formation, AF residues could be transferred from the laying
hen to the fertilized eggs, thereby resulting in decreased embryo viability and
hatchability (Qureshi et al., 1998), and causing several organ malformations (Cilievici
et al., 1979). In addition, the carry-over AF from layer’s feed to the embryonated eggs
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has also been attributed to retarding the development of chicken embryos as well as
inhibit the growth of bone tissue, especially tibia in chickens (Huff et al., 1980; Celik
et al., 2000).
Despite the ill effects of aflatoxicosis in chickens, cost-effective and practical
methods to prevent AF contamination in poultry feed are currently limited. At present,
the inclusion of AF-binding adsorbents in feed is employed to protect birds from the
harmful effects of AF. However, several adsorbents have been shown to impair
nutrient utilization (Chung et al., 1990; Kubena et al., 1993; Scheideler, 1993) and
mineral absorption in chickens (Chestnut et al., 1992; Edrington et al., 1997). Thus,
there is a need for an effective strategy to control aflatoxicosis in chickens.
In the past decade, the use of phytochemicals has gained significant attention
due to increasing concern over the safety of synthetic chemicals and emergence of
antibiotic-resistant strains of microorganisms (Salamci et al., 2007). The antifungal
and antitoxigenic properties of several plant oils have been identified (Upadhyaya et
al., 2014). Carvacrol (CR) is a major ingredient in oregano oil (Origanum
glandulosum), whereas trans-cinnamaldehyde (TC) is a principal component in
cinnamon bark (Cinnamomum zeylandicum). Both of these compounds are classified
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as generally recognized as safe (GRAS) for addition in food products by the US Food
and Drug Administration (USFDA) (Adams et al., 2004; Higueras et al., 2013).

In

previous studies, TC has been supplemented to chicken feed to reduce the
colonization of Salmonella Enteritidis in chickens without deleteriously affecting feed
intake and body weight of the birds (Kollanoor-Johny et al., 2012). Similarly, CR has
also been used as a feed additive to decrease Campylobacter jejuni carriage in
chickens (Arsi et al., 2014). These findings suggest that CR and TC, especially due to
their lipophilic nature, could be mixed with other feed ingredients in a poultry ration.
In this study, we investigated the efficacy of CR and TC in protecting chicken
embryos from AF-induced toxicity.
2. Materials and Methods
2.1 Experimental designs
Pure AFB1 (aflatoxinB1, 20 μg/ml in 100% methanol, catalogue no. CRM44647,
Sigma-Aldrich, St. Louis, MO) was diluted with sterile double-distilled water to
obtain final concentrations of 50 ng/20uL or 75 ng/20uL of AFB1 in 20% methanol.
The AFB1 concentration of the solutions was measured using a commercial ELISA
kit (AgraQuant total Aflatoxin, catalogue no. CAKAQ 1100, Romer Labs, Union,
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MO). To prepare the phytochemical treatments, CR or TC (99% purity, catalogue no.
W224502 and W228605, Sigma-Aldrich, St. Louis, MO) was added to the
aforementioned solution containing 50 ng or 75 ng of AFB1 to obtain a final
concentration at 0.1% of CR or TC in the 20ul injection volume.
Freshly laid fertile eggs from single-comb White Leghorn (Lohmann LSL-Lite,
Lohmann Tierzucht GmbH, Am Seedeich 9-11,27472 Cuxhaven, Germany) layer
chickens were procured from the University of Connecticut poultry farm. The various
treatments used in this study included (1) Negative control (eggs with no injection), (2)
0.1% CR control (eggs injected with 0.1% CR), (3) 0.1% TC control (eggs injected
with 0.1% TC), (4) Methanol control (eggs injected with 20% methanol), (5) AF 50
ng (eggs injected with 50 ng AFB1), (6) AF 75 ng (eggs injected with 75 ng AFB1),
(7) AF 50 ng + 0.1% CR (eggs injected with 50 ng AFB1 and 0.1% CR), (8) AF 50 ng
+ 0.1% TC (eggs injected with 50 ng AFB1 and 0.1% TC), (9) AF 75 ng + 0.1% CR
(eggs injected with 75 ng AFB1 and 0.1% CR), (10) AF 75 ng + 0.1% TC (eggs
injected with 75 ng AFB1 and 0.1% TC). Following the treatments, eggs were
incubated by placing in an incubator (catalogue no. 2362N hova-bator, GQF
Manufacturing Company Inc., Savannah, GA) at 37.8oC and 65% relative humidity,
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with eggs being turned through 270o every 2 h during incubation.
In total, one hundred and fifty fertile eggs were used for each study, and the
study was repeated three times. The eggs were weighed and divided into 10 groups
with 15 eggs per group. All eggs were candled to determine the viability of the fertile
eggs, and the treatments were applied just prior to placing the eggs in the incubator
(Celik et al., 2000; Oznurlu et al., 2012). To inject the eggs, 20 μl of each
aforementioned treatment solution was injected into the air space on the blunt end of
the egg using pipettes with sterile tips (Celik et al., 2000). After injection, the hole
was immediately sealed with melted paraffin (Oznurlu et al., 2012). The injected eggs
were incubated for 18 days.
2.2 Effect of phytochemicals on the growth of embryo when exposed to AFB1
On day 18 of incubation, fifteen eggs containing developing embryos from each
treatment group were individually weighed using a digital balance (sensitivity g±0.01,
catalogue no. 01-919-370, Fisher Scientific Co., Fair Lawn, NJ). The eggs were
opened, and the weights of the yolk sac and embryo were recorded for each egg
individually. The developmental stage of each embryo was determined according to
the Hamburger-Hamilton scale (Hamburger and Hamilton, 1951). The mean relative
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embryo weight and relative yolk sac weight of each group were calculated using the
equations as provided below:
Relative embryo weight = [(embryo weight/egg weight x 100)]; Relative yolk sac
weight = [(yolk sac weight/egg weight) x 100]
2.3 Effect of phytochemicals on the development of tibia in chicken embryo when
exposed to AFB1
Tibia from each embryo was removed, cleared of muscle and connective tissues,
and weighed. Tibia weights were expressed as relative tibia weight [(tibia
weight/embryo weight x 100)]. Tibia length was measured using a digital caliper
(sensitivity: mm±0.01).
2.4 Statistical analysis
Each experiment had ten treatments with 15 eggs/treatment (n=150
eggs/experiment) and each experiment was replicated three times. A completely
randomized design was used and egg was the experimental unit. The relative yolk sac
weight, embryo weight, tibia weight, and tibia length were analyzed by PROCGENMODE procedure of the statistical analysis software (SAS, version 9.2; SAS
Institute Inc., Cary, NC). Differences among the means were detected with a p value <
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0.05, using Fisher’s least significance difference (LSD).
3. Results
3.1 Effect of phytochemicals on embryo mortality when exposed to AFB1
Table 1 shows the mortality rates of embryos from all the treatment groups used
in this study. In control groups (negative, methanol, CR, and TC controls), mortalities
ranging from 4 to 9% with no developmental abnormalities observed. Mortality rates
in eggs injected with 50 ng AFB1 was 16%; however, a significantly greater mortality
of 68% was noticed when the eggs were exposed to 75 ng AFB1. Although no
significant difference was observed in the mortality rates between eggs treated with
50 ng AFB1 (16%) and 50 ng AFB1 + CR/TC (14% and 13%), 0.1% CR and TC
significantly reduced embryo mortality to 38% in the presence of 75 ng AFB1
(p<0.05).
3.2 Effect of phytochemicals on embryo weight and yolk sac weight when exposed
to AFB1
The relative embryo weight and relative yolk sac weight of all treatments and
controls on day 18th of incubation are depicted in Fig. 1a. and Fig. 1b. Results
revealed that injection of eggs with 20% methanol, 0.1% CR, or 0.1% TC did not
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significantly affect the relative embryo weight and relative yolk sac weight when
compared with the negative control (p>0.05). Eggs injected with 50 ng AFB1
demonstrated significantly lowered relative embryo weight as compared to the
negative control (p<0.05). Although no significant difference in the relative embryo
weights between AF 50 group and AF 50 + 0.1% CR groups (p>0.05) was observed,
eggs treated with 0.1% TC in the presence of 50 ng AFB1 demonstrated greater
relative embryo weights compared to those injected with 50 ng AFB1/egg alone (Fig
1a, Fig. 3).
Relative yolk sac weight of eggs injected with 50 ng AFB1/egg was found to be
significantly increased as compared to the negative control and methanol control
(p<0.05). In addition, 0.1% TC significantly decreased the relative yolk sac weight of
eggs treated with 50 ng AFB1. However, as the AFB1 concentration increased to 75
ng/egg, no difference in relative yolk sac weights was observed between eggs injected
with AFB1 and AFB1+phytochemical (p>0.05).
3.3 Effect of phytochemicals on embryo tibia length and weight when exposed to
AFB1
The effects of phytochemicals on tibia development in embryos exposed to
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AFB1 are shown in Fig. 2a. and 2b. Results revealed that the average relative tibia
weight of AFB1-injected embryos decreased in a dose-dependent manner in
comparison to controls (p<0.05). However, CR and TC increased the relative tibia
weight by 3.7% and 5%, respectively in embryos injected with 75 ng AFB1 as
compared to embryos exposed to AFB1 75 ng alone. Moreover, injection of 0.1% CR
and TC in the presence of 50 ng AFB1 significantly increased the embryo tibia length
by 14% as compared to the AF50 group.
4. Discussion
Aflatoxins can frequently contaminate chicken feed ingredients causing
aflatoxicosis in birds resulting in decreased growth performance and increased
susceptibility to infectious diseases. In addition, the transfer of AF from hens to eggs
not only poses a threat to public health, but the residual AF can deleteriously affect
embryo viability and hatchability, and potentially result in organ malfunctions
(Cilievici et al., 1979; Qureshi et al., 1998; Sur et al., 2011). Thus, effective methods
to protect fertilized eggs from aflatoxicosis is critical for the sustainability of the
poultry industry.
Previous studies have reported that the development of chicken embryos was

94

adversely affected in the presence of 10-100 ng of AFB1/egg (Celik et al., 2000;
Oznurlu et al., 2012). Therefore, in the present study, we investigated the efficacy of
CR and TC in protecting chicken embryos from AFB1 toxicity at concentrations,
namely 50 ng AFB1/egg or 75 ng AFB1/egg. Our results revealed that the higher dose
of AFB1 caused significant embryonic mortality (68%), whereas 50 ng AFB1/egg
only resulted in 16% mortality (Table 1.) Additionally, the presence of 0.1% CR or
TC significantly reduced the mortality rates to 14% or 13% and 38% when embryos
were exposed to 50 ng or 75 ng AFB1/egg, respectively.
One of the major effects of aflatoxicosis on birds is decreased body weight,
which directly affects the profitability of the poultry industry. Aflatoxin B1 is known
to cause inhibition of RNA and DNA synthesis, thereby consequently reducing
protein synthesis, which ultimately reduces growth (Hatch, 1988; Khlangwiset et al.,
2011). As expected, egg injection with 50 ng or 75 ng of AFB1 significantly
decreased the relative embryo weight compared to controls (Fig. 1a). However, both
phytochemicals improved the embryo weight despite exposure to AFB1, suggesting
the potential protective effect of CR and TC to AFB1-injected embryos (Fig. 3).
Additionally, egg yolk is the main energy source for the developing embryo,
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which supplies more than 90% of the total energy requirements of the embryo by
oxidation of yolk lipids (Speake et al., 1998; Réhault-Godbert et al., 2014). The yolk
sac is an external extra-embryonic tissue that surrounds the yolk, and absorbs, digests,
and transports nutrients during incubation of the chicken embryo (Yadgary et al.,
2014). Moreover, yolk sac and yolk content are essential for supporting the
development of the embryo during the entire phase of embryogenesis (Speake et al.,
1998; Yalcin et al., 2008). In the present study, we found a significant increase of
relative yolk sac weight in eggs injected with 50 ng AFB1 compared to controls,
which indicates reduced development of the embryos in the toxin-treated eggs. This
concurs with our embryo weight data (Fig. 1a), which revealed that the relative
embryo weights were significantly reduced in AFB1-injected eggs.
Aflatoxin B1 has also been reported to inhibit the development and growth of
bone tissue in chickens, resulting in the retardation of the skeleton system
development, especially the tibia (Huff et al., 1980). In the present study, 50 ng of
AFB1/egg reduced tibia length, whereas 75 ng of AFB1/egg reduced relative tibia
weight and tibia length compared to the negative control (p<0.05). Supplementation
of 0.1% CR or TC in the presence of 50 ng AFB1/egg significantly improved the
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relative tibia length as compared to embryos injected with AFB1 alone (p<0.05).
However, the protective effects of CR and TC on the embryos did not persist when the
AFB1 level was increased to 75 ng/egg, where no significant improvement in tibia
length was observed in the presence of 0.1% CR or 0.1% TC as compared to controls
(Fig. 2b.).
The toxic effects of AFB1 are well documented (Moudgil et al., 2013; Bahey et
al., 2015), where several studies have confirmed that AFB1 is metabolized to a more
active form, AFB1-2,3 epoxide, by cytochrome P450 family enzymes in the liver.
This active compound avidly binds to N-guanine in DNA, and is shown to mediate
cytotoxic, carcinogenic, and mutagenic effects (Eaton and Gallagher, 1994; Oznurlu
et al., 2012). Although there is scanty information about the detoxification
mechanisms of early embryonic cells, studies have shown that chicken embryos
obtain the ability of detoxification shortly after the development of liver by day 5 to
day 6 of incubation, (Hamilton and Bloom, 1986; Zhao and Duncan, 2005). Although
the mechanism(s) of the protective effects of phytochemicals to AF-induced toxicity
to chicken embryos have not yet been documented, Abdel-Aziem et al. (2014), while
evaluating the hepatoprotective effect of thyme leave extracts (contains CR) on AF-
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induced oxidative stress, genotoxicity, and alteration of p53 and bal gene expressions
in rats, observed that animals treated with the extracts showed a significant decrease
in oxidative damage markers, micronucleated cells, DNA fragmentation, and
modulation of the expression of pro-apoptotic genes. Thus, the reduced AF toxicity
observed in the chicken embryos could potentially be attributed to the protective
effects of the phytochemicals in the liver. However, more in-depth molecular
investigations need to be performed to elucidate the protective mechanisms of the
phytochemicals.
In previous studies, TC has been supplemented to chicken feed to reduce the
colonization of Salmonella Enteritidis in chickens without deleteriously affecting feed
intake and body weight of birds (Kollanoor-Johny et al., 2012). Similarly, CR has also
been used as a feed additive to decrease Campylobacter jejuni carriage in chickens
(Arsi et al., 2014). These findings suggest that CR and TC, especially due to their
lipophilic nature, could be mixed with other feed ingredients in a poultry ration.
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Table 1. Effect of 0.1% carvacrol and 0.1% trans-cinnamaldehyde on embryo
mortality when exposed to 50 ng or 75 ng AFB1/egg for 18 days.1,2

1

Group

Mortality

Control

7%

Methanol

5%

CR

4%

TC

7%

AF50

16%

AF50 CR

14%

AF50 TC

13%

AF75

68%

AF75 CR

38%

AF75 TC

38%

Control: eggs with no injection; Methanol: eggs injected with 20% methanol; CR:

eggs injected with 0.1% CR only; TC: eggs injected with 0.1% TC only; AF50: eggs
injected with 50 ng AFB1; AF 50 CR: eggs injected with 50 ng AFB1 and 0.1% CR;
AF 50 TC: eggs injected with 50 ng AFB1 and 0.1% TC; AF 75: eggs injected with 75
ng AFB1; AF 75 CR: eggs injected with 75 ng AFB1 and 0.1% CR; AF 75 TC: eggs
injected with 75 ng AFB1 and 0.1% TC. 2Each treatment group had 45 eggs/treatment.
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Figure 1. Effect of carvacrol and trans-cinnamaldehyde on the growth of chicken
embryo when exposed to AFB1 at 50 ng and 75 ng /egg. Data are the mean ± SEM
obtained from 3 separate experiments with 15 eggs per treatment group. Error bar
indicates SEM (n=45/treatment). Fig. 1a shows the relative embryo weight and 1b
shows the relative yolk sac weight. a-c Means treatments differed significantly from
the negative control (p<0.05).
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Figure 2. Effect of carvacrol and trans-cinnamaldehyde on the development of tibia
in chicken embryo when exposed to AFB1 at 50 ng and 75 ng /egg. Data are the mean
± SEM obtained from 3 separate experiments with 15 eggs per treatment group. Error
bar indicates SEM (n=45/treatment). Fig. 1a shows the relative tibia weight and 1b
shows the tibia length. a-d Means treatments differed significantly from the negative
control (p<0.05).
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Figure 3. Chicken embryos from different treatments. Treatments include Control:
eggs with no injection; Methanol: eggs injected with 20% methanol; CR: eggs
injected with 0.1% CR only; TC: eggs injected with 0.1% TC only; AF50: eggs
injected with 50 ng AFB1; AF 50 CR: eggs injected with 50 ng AFB1 and 0.1% CR;
AF 50 TC: eggs injected with 50 ng AFB1 and 0.1% TC; AF 75: eggs injected with 75
ng AFB1; AF 75 CR: eggs injected with 75 ng AFB1 and 0.1% CR; AF 75 TC: eggs
injected with 75 ng AFB1 and 0.1% TC.
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Chapter V
Efficacy of in-feed supplementation of phytochemicals in reducing aflatoxicosis
in chickens
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ABSTRACT
Aflatoxins (AF) are a group of secondary metabolites produced by Aspergillus flavus
and Aspergillus parasiticus, which frequently contaminate a variety of poultry feed
ingredients. Contamination of poultry feed with AF is a major concern to the poultry
industry since aflatoxicosis in chickens results in significant economic losses due to
poor feed utilization, decreased body weight, and increased mortality. In this study,
we investigated the efficacy of two generally recognized as safe phytochemicals,
namely carvacrol (CR) and trans-cinnamaldehyde (TC), in controlling aflatoxicosis in
chickens. Day-old broiler chicks were fed with AF contaminated feed (~2.5 µg/g)
with or without in-feed supplementation of 0.75% CR or TC for 5 weeks. In weeks 2,
3, 4, and 5, chicken performance traits, including body weight, feed intake, and feed
conversion rate were measured. In addition, the relative weights of liver, spleen, and
bursa of Fabricius were determined, and histologic analysis of liver was performed.
Results revealed that CR and TC supplementation in AF-contaminated feed
ameliorated AF-induced adverse effects in chickens. In addition, phytochemical
supplementation significantly decreased relative liver weight and improved relative
bursa of Fabricius weight in birds, as compared to AF-treated group (P < 0.05).

109

Histologic analysis revealed that CR and TC reduced AF-induced toxic effects in the
liver of birds, where phytochemical-treated chickens had decreased hepatocellular
degeneration, necrosis and inflammation in the liver as compared to chickens fed with
AF alone. Results suggest that CR and TC could potentially be used as feed additives
to control aflatoxicosis in broiler chickens.
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1. Introduction
Aflatoxins (AF) are a group of fungal toxic metabolites of Aspergillus flavus and
Aspergillus parasiticus. Among the 18 types of identified AF, AFB1, B2, G1, and G2
are the natural contaminants of a variety of feed ingredients, including peanuts, corn
and cottonseed (Oguz et al., 2000; Sur and Celik, 2003). In addition, AFB1 is
considered to be one of the most potent hepatotoxins and well-known
hepatocarcinogens (Wilson and Payne, 1994). Contamination of poultry feed with AF
is a significant concern to the poultry industry since aflatoxicosis in chickens results
in significant economic losses due to poor feed utilization, decreased body weight,
reduced egg production, and increased mortality (Qureshi et al., 1998; Tessari et al.,
2006; Oguz, 2011). Since the first outbreak of AF contamination occurred in 1960, the
negative effects of AF in poultry have been widely investigated (Giambrone et al.,
1978; Celik et al., 1996; Sur and Celik, 2003). Once ingested by chickens, AF can
accumulate in most of the soft tissues and fat depots of birds resulting in hemorrhagic
and enlarged liver (Leeson et al., 1995; Bintvihok et al, 2002). In addition, AF
residues found in poultry meat and eggs (Jacobson and Wiseman, 1974; Sudhakar,
1992; Qureshi et al, 1998) pose a significant health hazard to humans due to their
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carcinogenic, teratogenic, and mutagenic properties (Ross et al., 1992; Bintvihok et
al., 2002). Thus, it is critical to control aflatoxicosis in poultry to protect public health,
bird health, and ensure the economic viability of the poultry industry.
The Food and Agriculture Organization reported that 25% of the world’s grains
are contaminated by mycotoxins, and AF contamination is the most common among
them. The economic losses due to AF contamination to the US poultry industry
exceed $143 million annually (CAST, 1989). However, cost-effective and practical
methods to prevent AF contamination in poultry feed are currently limited. At present,
the inclusion of AF-binding adsorbents in feed is employed to protect birds from the
harmful effects of AF. However, several adsorbents have been shown to impair
nutrient utilization (Chung et al., 1990; Kubena et al., 1993; Scheideler et al., 1993)
and mineral absorption in chickens (Chestnut et al., 1992; Ramos et al., 1996;
Edrington et al., 1997). It was concluded that none of the current strategies to control
AF are sufficient to completely fulfill the necessary safety and cost requirements
(Teniola et al., 2005). This highlights the need for an effective strategy to control
aflatoxicosis in chickens.
Historically, plants have served as a source for the development of novel drugs,
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thereby contributing to human health and well-being (Cowan, 1999). A variety of
phytochemicals have traditionally been used as food preservatives and flavor
enhancers (Pitasawat et al., 2007). Among the various phytochemicals, carvacrol (CR),
listed as generally recognized as safe (GRAS) by the FDA, is a major component in
oregano oil obtained from Origanum vulgare (Lamiaceae). Carvacrol has been found
effective against bacterial and fungal infections of the gastrointestinal and
genitourinary tract (Blumenthal et al., 2000; Adams et al., 2004; Chun et al., 2005) as
well as against a wide range of pathogens, including Staphylococcus aureus,
Escherichia coli, and Streptococcus pneumoniae (Hersch-Martinez et al., 2005).
Trans-cinnamaldehyde (TC) is another GRAS-status ingredient present in the bark
extract of cinnamon (Cinnamomum zeylandicum). Various studies have demonstrated
the antimicrobial properties of TC against both gram-negative and -positive bacteria
(Burt, 2004; Upadhyaya et al., 2014). Previously, we observed that CR and TC were
effective in killing A. flavus and A. parasiticus as well as reducing AF production in
chicken feed for up to 3 months of storage (Yin et al., 2015). In the current study, we
investigated the efficacy of in-feed supplementation of CR and TC in reducing
aflatoxicosis in chickens.
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2. Materials and Methods
2.1 Method of AF production
To ensure AF production in adequate quantity for bird feeding experiments, a
published protocol using rice as an initial substrate for AF production was used
(Shotwell et al., 1966; Schroeder et al. 1973; Gowda et al., 2008). Briefly, 100 g of
rice placed in a 1 liter Erlenmeyer flask was cleaned, washed, and immersed in 15 ml
of sterile water for at least 2 hours. After 2 hours, rice was autoclaved and inoculated
with 10 ml of A. parasiticus NRRL 2999 inoculum (~ 108 CFU/ml). Flasks were
incubated at 27oC for 24 hours followed vigorous shaking in a shaking incubator at
250 rpm at 25oC for 7 days. After incubation, the rice was dried and ground in an
electric blender, and its AFB1 concentration was determined using a commercial
ELISA kit (AgraQuant Aflatoxin B1, catalogue no. CAKAQ 8000, Romer Labs,
Union, MO, USA). Based on the AFB1 level detected in the rice powder, appropriate
amounts of the powder were added to chicken feed to reach a final concentration of
2.5 µg/g in the feed. Additionally, experimental feed in the phytochemical-treated
groups was supplemented with CR or TC (99% purity, catalogue no. W224502 and
W228605, Sigma-Aldrich, St. Louis, MO, USA) to obtain 0.75% (vol/wt) in the feed.
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This concentration was selected based on a previous study from our laboratory, where
in-feed supplementation of 0.75% TC produced no deleterious effects on chicken
performance (Kollanoor-Johny et al., 2012).
2.2 Experimental birds and housing
All experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Connecticut. Day-old broiler chicks (Ross x
Ross) were obtained from a commercial hatchery and randomly assigned to floor pens
provided with ad libitum feed, water, age-appropriate ambient temperatures, and
bedding at the Poultry Isolation Facility of the University of Connecticut. Mortality
was recorded as it occurred, and birds were inspected daily for signs of health-related
problems.
2.3 Broiler chickens, diets, and management
A total of 240 chickens were randomly assigned to 6 different treatments with 20
birds per pen and two pens per treatment. The 6 treatment groups included: (1)
Control (feed with no AF and no CR/TC supplementation), (2) CR control (feed with
no AF, but 0.75% supplemental CR), (3) TC control (feed with no AF, but 0.75%
supplemental TC), (4) AF (feed containing ~2.5 µg/g AF), (5) AF+CR (feed
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containing ~2.5 µg/g AF and 0.75% supplemental CR), and (6) AF+TC (feed
containing ~2.5 µg/g AF and 0.75% supplemental TC). Control and treatment feed
was provided for the entire experimental period of 35 days.
2.4 Growth performance
Five birds per pen per treatment were euthanized using CO2 asphyxiation in
weeks 2, 3, 4, and 5. Individual body weight (BW) was measured at each time point.
Average feed intake and body weight gain was corrected for mortality when
calculating feed conversion ratio (FCR) as kg feed consumed/ kg body weight gain
for each treatment.
2.5 Organ sample collection
At each time point (week 2, week 3, week 4, and week 5), entire organs of liver,
spleen, and bursa of Fabricius were collected and weighed (Aravind et al., 2003).
Relative organ weights were calculated as a percentage of BW.
2.6 Histologic examination of liver
In weeks 3 and 5, a portion of liver from three different birds from each group
was rapidly fixed in 10% neutral buffered formalin solution for at least 24 hours, and
stored at room temperature until subjected to histologic analysis (Tedesco et al., 2004).
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The liver samples were dehydrated through a graded series of ethanol, cleared in
xylene, embedded in paraffin wax, and sectioned at 5 µm with microtome. The
sections were stained with hematoxylin and eosin (H&E), according to the method
described by Culling (1983). The slides were examined using a light microscope
equipped with a digital camera (catalogue no. BA410E, Elite Biological Light
Microscope, Motic, British Columbia, Canada).
2.7 Feed composition analysis
To study the effect of CR and TC on feed composition, wet chemistry analysis
was used, as previously described (Harris, 2010). Briefly, 1 kg of the CR or TC
treatment feed was subjected to analysis for composition parameters included
moisture (%), dry matter (%), crude protein (%), digestion energy (%), and essential
mineral concentrations. The feed samples were analyzed at a commercial feed testing
company (Dairy One Laboratory Services, Ithaca, NY).
2.8 Statistical analysis
A completely randomized design was followed in the experiment. Broiler
performance (BW, Feed intake, and FCR) data included 6 treatments, 10
samples/treatment at each time point, and 4 time points (week 2, 3, 4, and 5). Organ
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weight data (liver, spleen, and bursa of Fabricius) included 6 treatments, 10
samples/treatment at each time point, and 4 time points (week 2, 3, 4, and 5). Feed
composition data included 3 treatments (control, 0.75% CR, and 0.75% TC). PROCGENMOD procedure of the statistical analysis software (version 9.1, SAS Institute
Inc. Cary, NC) was used. Differences among the means were detected at P < 0.05
using Fisher’s Least Significance Difference (LSD) test with appropriate correction
for multiple comparisons.
3. Results
3.1 Growth performance
No morbidity or mortality of birds due to AF ingestion was recorded in this study.
The average BW of each experimental group is shown in Figure 1. In weeks 4 and 5,
control birds had the maximum BW. Aflatoxin supplementation at 2.5 µg/g
significantly reduced chicken BW in week 4 and week 5 by ~11% and ~18%,
respectively as compared to control (P < 0.05). Although the results were not
significant (P > 0.05), birds supplemented with TC at 0.75% were generally heavier
than the AF-treated birds. However, in-feed supplementation of CR at 0.75%
significantly increased the BW of the birds fed with 2.5 µg/g AF by ~ 13% as
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compared to chickens fed with AF alone in week 5. However, feed intake and FCR
were not significantly affected by the treatments. (Table 1)
3.2 Relative organ weight
Table 2 shows the effect of CR and TC on the relative liver weight in chickens
exposed to AF. Results indicated that the relative liver weight from AF-treated
chickens was significantly greater in week 3 and week 5 as compared to the control (P
< 0.05). In addition, in-feed supplementation of CR and TC significantly decreased
the relative liver weight in birds compared to the AF-treated group (P < 0.05).
Similarly, chickens fed with AF-contaminated feed demonstrated a significantly
decreased relative bursa of Fabricius weight compared to other treatment groups
(Table 3). No significant differences in relative bursa of Fabricius weight were
observed among other treatment groups throughout the study. Relative spleen weights
among the various treatment groups were not significantly different at any sampling
point (P > 0.05, data not shown).
3.3 Liver histologic analysis
Figure 2 shows the histologic analysis of liver from birds in week 3. Liver
samples from control, 0.75% CR control, and 0.75% TC control revealed no
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significant lesions and appeared normal (Fig. 2). Liver samples from AFsupplemented chickens demonstrated moderate to severe hepatocellular degeneration,
necrosis, and lymphoplasmacytic infiltration. However, the liver from birds fed with
AF + CR or TC showed a lesser inflammatory infiltration and minimal hepatocellular
degeneration and necrosis compared to the birds fed with AF alone (Fig. 2). No
significant differences in the histologic analysis of liver among the treatment groups
were observed in week 5 (data not shown).
3.4 Feed composition
Feed composition analysis revealed no significant differences in moisture (%),
dry matter (%), crude protein (%), acid detergent fiber (%), neutral detergent fiber (%),
and the total energy (%) between control and phytochemical supplemented samples (P
> 0.05). In addition, supplementation of CR or TC did not significantly affect the
essential mineral content, including calcium (%), phosphorus (%), magnesium (%),
potassium (%), sodium (%), manganese (µg/g), zinc (µg/g), copper (µg/g), iron (µg/g)
(P > 0.05).
4. Discussion
Aflatoxin contamination has been detected in poultry feed ingredients at pre- and
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post-harvest, and after processing and packaging of feed ingredients (CAST, 1989).
Ingestion of AF-contaminated feed results in chicken aflatoxicosis affecting bird
health and performance. In addition, the adverse effects on public health due to the
consumption of AF-contaminated poultry products constitute a significant hazard. The
current study was designed at evaluating the efficacy of in-feed supplementation of
CR and TC in reducing aflatoxicosis in broiler chickens.
Several studies have reported the adverse effects of AF on the performance of
poultry, including BW (Dersjant-Li et al., 2003; Yunus et al., 2011). In the current
study, we found a significant reduction in BW (when 2.5 µg/g AF diet was fed to
broilers for 4 and 5 weeks) as compared to the control (Fig. 1), which is consistent
with the study by Miazzo et al. (2000), who reported a 11% reduction in body weight
gain at 2.5 µg/g of AF supplemented in the feed. However, we observed a reduction of
BW due to AF exposure in birds only after 28 days of the experimental period (Table
1 and Fig. 1). In addition, we did not observe any effect of AF on the feed intake and
FCR in chickens, which concurred with the findings of Maizzo et al. (2000) and
Pimpukdee et al. (2004) (Table 1). The effects of AF on feed intake and FCR are not
always consistent because they depend on the composition of experimental diets,
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particularly different protein sources and levels, which were reported to alter protein
utilization and animal response to AF in poultry (Richardson et al., 1987; Coffey et al.,
1989).
The toxicity of AF is initiated through bioactivation to its toxic intermediates,
which is mediated by cytochrome P450 enzymes located in the liver, thus making the
liver the primary target for AF toxicity (Wogan, 1999; Wild and Turner, 2002).
Furthermore, it has been documented that the negative effects of AF on chicken
performance might be attributed to its harmful effects on liver weight and the liver
function. In the current study, we observed a significantly increased relative liver
weight in chickens fed with 2.5 µg/g AF as compared to the control group (Table 2).
The enlarged liver may be due to the fatty infiltration and tissue proliferation (Eraslan
et al., 2004; Shi et al., 2009) brought about by AF. In addition, it has been suggested
that AF may generate a more profound toxicosis in modern broilers because of the
rapid growth that requires faster hepatic metabolism (Yunus et al., 2011). In line with
these observations, histopathological analysis of the enlarged liver collected from the
AF-treatment group revealed severe necrosis, bile duct proliferation, and
hypertrophied liver cells as compared to the control. However, these lesions were
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found to be alleviated in the liver samples from phytochemical-treated groups (Fig. 2).
Thus, the findings from this study suggest the potential ability of CR and TC to
counteract the harmful effects of AF, especially in reducing hepatic pathology changes
induced by the toxin.
Apart from the toxicity of AF on the liver, the immunosuppressive nature of AF
is another well-documented adverse effect on birds (Yunus et al., 2011). Aflatoxin
consumption has been reported to cause vaccine failure (Mohiuddin and Reddy, 1993)
due to AF-induced decrease in antibody titers against Newcastle disease vaccine
(Mohiuddin and Reddy, 1993; Yunus et al., 2009) and decreased adaptive immunity
(Ghosh et al., 1990). Verma et al. (2004) found a decreased relative weight of bursa of
Fabricius from chickens fed with 2.0 µg/g AF. In the present study, results showed
that the lymphoid organ, bursa of Fabricius of chickens given AF were markedly
reduced in size, whereas CR and TC supplementation in the presence of AF
significantly improved the relative bursa of Fabricius weight in week 4 when
compared to AF-alone group (Table 3).
The mechanism of action of CR and TC against AF-induced toxicity is not yet
documented. However, Ramirez et al. (2012) reported that CR was able to inhibit the
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activity of P450 enzymes in vitro. Since the toxicity of AF is initiated from a complex
metabolism by P450 enzymes in the liver, the reduced activity of P450 might be one
of the potential protective mechanisms of phytochemicals to reduce aflatoxicosis in
chickens. In addition, CR and TC are known to be potent antioxidants that can act as a
scavenger of free radicals (Aeschbach et al., 1994; Gowder and Devaraj, 2006; Chen
et al., 2009) and can influence the activities of enzymes that are associated with AF
detoxification. For example, Gowder and Devaraj (2006) observed that the activity of
glutathione S-transferase (GST) was significantly increased in rats that were orally
given cinnamaldehyde for 90 days. The increase in the level of GST might potentially
increase the detoxification of AF-related toxic intermediates during AF metabolism in
the liver and increase the excretion of toxic AF intermediates through urine and bile
(Essigmann et al., 1982; Wild and Turner, 2002). However, these findings need to be
validated in chickens.
According to the results from wet chemistry analysis for feed composition, no
differences were noticed between the control (basal diet) and the phytochemicalsupplemented feeds (P > 0.05) (Table 4), which supports the use of the
phytochemicals as feed additives. Moreover, due to the lipophilic nature of CR and
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TC, they can be easily mixed with other feed ingredients in a poultry ration. In
conclusion, this study demonstrated that in-feed supplementation of CR and TC at
0.75% reduced aflatoxicosis in chicken by improving bird performance and reducing
AF-induced toxicity in liver. The results suggest that CR and TC could potentially be
used as feed additives to control chicken aflatoxicosis; however, follow up studies
under field conditions using a large of number of birds are warranted.
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Table 1. Effect of in-feed supplementation of CR and TC on performance in chickens
fed with 2.5 µg/g AF1. CR: carvacrol; TC: trans-cinnamaldehyde; AF: aflatoxins1,2.
Body weight
g/chicken

Daily feed intake
g/chicken

Feed conversion ratio

Treatments3

35d

0-35d

0-35d

Control
CR control
TC control
AF
AF + CR
AF + TC
SEM2

3241a
2818 c
2902 bc
2650 d
2987 c
2789 cd
84

148
136
137
131
130
137
3

1.42
1.52
1.50
1.52
1.37
1.57
0.031

a-d

Means with different superscripts in a column differ significantly (P < 0.05).

1

Means represent 5 birds per pen and two pens per treatment.

2

Pooled standard error of the mean.

3

Treatments include Control: feed with no AF and no CR/TC supplementation; CR

control: 0.75% carvacrol control; TC control: 0.75% trans-cinnamaldehyde control;
AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol; AF+TC: 2.5
µg/g aflatoxins + 0.75% trans-cinnamaldehyde.
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Table 2. Effect of in-feed supplementation of CR and TC on relative liver weight of
chickens fed with 2.5 µg/g AF. CR: carvacrol; TC: trans-cinnamaldehyde; AF:
aflatoxins1,2.
3

Relative Liver Weight
Week 3
Week 4

Items
CR
Treatments

Week 2

Control

3.42% ± 0.71%a

2.50% ± 0.44% a

2.52% ± 0.34% a

2.44% ± 0.31% a

CR control
AF
AF + CR
TC
Treatments
Control
TC control
AF
AF + TC

3.45% ± 0.90%a
3.69% ± 0.41%a
3.79% ± 0.34%a

2.83% ± 0.48% ab
3.04% ± 0.66% b
2.65% ± 0.31% ab

2.51% ± 0.21% a
2.74% ± 0.30% a
2.59% ± 0.28% a

2.35% ± 0.27% a
2.73% ± 0.41% b
2.40% ± 0.19% a

3.42% ± 0.71%a
3.49% ± 0.50% a
3.69% ± 0.41%a
3.53% ± 0.55% a

2.50% ± 0.44% a
2.54% ± 0.32% a
3.04% ± 0.66% b
2.56% ± 0.51% a

2.52% ± 0.34% ab
2.53% ± 0.23% ab
2.74% ± 0.30% b
2.35% ± 0.40% a

2.44% ± 0.31% a
2.41% ± 0.35% a
2.73% ± 0.41% b
2.38% ± 0.09% a

a-b

Week 5

Means with different superscripts in a column differ significantly (P < 0.05).

1

Means represent 5 birds per pen and two pens per treatment.

2

Data are the mean ± SEM obtained from 5 birds per pen and two pens per treatment.

Error bar indicates SEM (n=10/treatment).
3

Treatments include Control: feed with no AF and no CR/TC supplementation; CR

control: 0.75% carvacrol control; TC control: 0.75% trans-cinnamaldehyde control;
AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol; AF+TC: 2.5
µg/g aflatoxins + 0.75% trans-cinnamaldehyde.
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Table 3. Effect of in-feed supplementation of CR and TC on relative bursa of
Fabricius weight of chickens fed with 2.5 µg/g AF. CR: carvacrol; TC: transcinnamaldehyde; AF: aflatoxins1,2.

Items
CR
Treatments
Control
CR control
AF
AF + CR
TC
Treatments
Control
TC control
AF
AF + TC
a-b

Week 2

Relative Bursa of Fabricius Weight
Week 3
Week 4

Week 5

0.20% ± 0.09% a
0.16% ± 0.10% a
0.20% ± 0..06% a
0.17% ± 0.04% a

0.20% ± 0.04% a
0.24 ± 0.09%% a
0.19% ± 0.08% a
0.21% ± 0.03% a

0.23% ± 0.06% a
0.21% ± 0.04% a
0.16% ± 0.03% b
0.21% ± 0.05% a

0.19% ± 0.03% a
0.17% ± 0.05% a
0.13% ± 0.03% b
0.14% ± 0.02% b

0.20% ± 0.09% a
0.17% ± 0.04% a
0.20% ± 0.06% a
0.18% ± 0.06% a

0.20% ± 0.04% a
0.19% ± 0.04% a
0.19% ± 0.08% a
0.18% ± 0.05% a

0.23% ± 0.06% a
0.18% ± 0.03% a
0.16% ± 0.03% b
0.20% ± 0.03% a

0.19% ± 0.03% a
0.18% ± 0.03% a
0.13% ± 0.03% b
0.18% ± 0.04% a

Means with different superscripts in a column differ significantly (P < 0.05).

1

Means represent 5 birds per pen and two pens per treatment.

2

Data are the mean ± SEM obtained from 5 birds per pen and two pens per treatment.

Error bar indicates SEM (n=10/treatment).
3

Treatments include Control: feed with no AF and no CR/TC supplementation; CR

control: 0.75% carvacrol control; TC control: 0.75% trans-cinnamaldehyde control;
AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol; AF+TC: 2.5
µg/g aflatoxins + 0.75% trans-cinnamaldehyde.
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Table 4. Effect of carvacrol (CR) and trans-cinnamaldehyde (TC) supplementation on
feed composition.

Moisture %
Dry Matter %
Crude Protein %
Acid Detergent Fiber %
Neutral Detergent Fiber %
Total Digestible Energy %
Calcium, %
Phosphorus, %
Magnesium, %
Potassium, %
Sodium, %
Manganese, µg/g
Zinc, µg/g
Copper, µg/g
Iron, µg/g
1

Control1
9.8
90.3
17.8
10.7
26.3
70
0.93
0.83
0.3
0.78
0.143
194
213
26
231

0.75% CR2
9.9
90.2
17.4
10
22.2
71
0.92
0.81
0.29
0.75
0.138
192
214
25
223

0.75% TC3
11.6
88.4
17.6
9
23.2
69
0.88
0.78
0.29
0.7
0.149
186
206
21
231

Control: no CR/TC supplementation

2

0.75% CR: 0.75% carvacrol

3

0.75% TC: 0.75% trans-cinnamaldehyde
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Figure 1. Effect of in-feed supplementation of CR and TC on body weight of
chickens fed with 2.5 µg/g AF. Control: feed with no AF and no CR/TC
supplementation; CR control: 0.75% carvacrol control; TC control: 0.75% transcinnamaldehyde control; AF: 2.5 µg/g aflatoxins; AF+CR: 2.5 µg/g aflatoxins +
0.75% carvacrol; AF+TC: 2.5 µg/g aflatoxins + 0.75% trans-cinnamaldehyde. Data
are the mean ± SEM obtained from 5 birds per pen and two pens per treatment. Error
bar indicates SEM (n=10).

a-c

indicates means with different superscripts differ

significantly (P < 0.05)
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Figure 2. Effect of in-feed supplementation of CR and TC on liver histopathology in
chickens fed with 2.5 µg/g AF in week 3. (A) Control: feed with no AF and no CR/TC
supplementation [hematoxylin and eosin (H and E) stain, × 100]; (B) CR control:
0.75% carvacrol control (H and E stain, × 100); (C) TC control: 0.75% transcinnamaldehyde control (H and E stain, × 200); (D) AF: 2.5 µg/g aflatoxins (H and E
stain, × 100); (E) AF+CR: 2.5 µg/g aflatoxins + 0.75% carvacrol (H and E stain, ×
100); (F) AF+TC: 2.5 µg/g aflatoxins + 0.75% trans-cinnamaldehyde (H and E stain,
× 200).
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Chapter VI
Effect of in-feed supplementation of phytochemicals on the hepatic
transcriptome of broiler chickens exposed to aflatoxin
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ABSTRACT
Aflatoxins (AF) are hepatotoxic metabolites produced by Aspergillus flavus and
Aspergillus parasiticus, which frequently contaminate poultry feed ingredients.
Contamination of poultry feed with AF is a major concern to the poultry industry,
since aflatoxicosis in chickens results in significant economic losses due to decreased
chicken performance and increased mortality. Our previous research revealed that infeed supplementation of two GRAS (generally recognized as safe)-status
phytochemicals, namely carvacrol (CR) and trans-cinnamaldehyde (TC), significantly
reduced aflatoxicosis in broiler chickens and decreased AF-induced toxic effect in
chicken liver. In this study, we investigated the effect of in-feed supplementation of
CR and TC on the hepatic transcriptome of chickens exposed to AF. Chicken livers
were collected from birds fed with AF contaminated feed (~2.5 ppm) with or without
supplementation of 0.75% CR or TC for 3 weeks. Whole transcriptome profile of
liver samples from control and treated chickens were analyzed using RNA-seq on
Illumina NextSeq 500 platform. Briefly, total RNA was extracted from chicken liver
(5 liver samples/ group), and RNA-seq libraries were created and run on four flow
cell lanes to produce over 340 million paired-reads totaling 36.8 Gb of sequence.
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Approximately, 29,181 predicated transcripts were mapped to the reference chicken
genome, of which 548 genes had significant differential expression in at least one
pair-wise comparison between control and treatment groups. Results revealed that
pathways and genes that are associated with hepatic diseases and lipid metabolism
were affected by AF diet compared to control; however, supplementation of CR and
TC to AF diet modulated genes involved in these pathways. Genes identified through
transcriptome analysis provide candidates for further study of aflatoxicosis in
chickens, and elucidate the potential protective mechanisms to liver mediated by CR
and TC from aflatoxicosis in chickens.
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1. Introduction
Aflatoxins (AF), a group of fungal toxic metabolites of Aspergillus flavus and
Aspergillus parasiticus, are common contaminants of poultry feed (Oguz et al., 2000;
Sur and Celik, 2003). Aflatoxicosis in chickens causes significant economic losses to
the poultry industry due to poor feed utilization, decreased body weight gain, reduced
egg production and increased mortality (Qureshi et al., 1998; Tessari et al., 2006;
Oguz, 2011). Aflatoxicosis is estimated to cost the poultry industry over $143 million
in economic losses each year (CAST, 1989). Once ingested by chickens, AF can
accumulate in most of the soft tissues and fat depots of birds resulting in hemorrhagic
and enlarged liver (Leeson et al., 1995; Bintvihok et al, 2002). Aflatoxin B1 (AFB1) is
one of the most potent hepatocarcinogens, and the toxicity of AFB1 is initiated by its
active metabolite, AF-8, 9-epoxide, which is metabolized by several P450 cytochrome
(CYP) enzymes in liver. This active metabolite binds to proteins and forms adducts
such as AFB1-lysine in albumin, besides binding to guanine residues in DNA and
forming guanyl-N7 adducts initiating the formation of hepatocarcinomas (Hsu et al.,
1991). Due to its carcinogenic properties, AFB1 has been listed as a group I human
carcinogen by the International Agency for Research on Cancer (Yunus et al., 2011).
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Thus, it is critical to control AF in poultry feed to protect public health, bird health,
and to ensure the economic viability of the poultry industry. Our previous research
revealed that in-feed supplementation of two GRAS (generally recognized as safe)status phytochemicals, namely carvacrol (CR) and trans-cinnamaldehyde (TC),
effectively reduced aflatoxicosis in broiler chickens, where a decreased AF-induced
toxic effect in liver was observed (Yin et al., 2015b). Carvacrol (CR) is a major
component in oregano oil obtained from Origanum vulgare (Lamiaceae), a common
herb found in Europe and the Mediterranean. Carvacrol has been documented to exert
antimicrobial activity against a wide range of microorganisms (Upadhyay et al., 2014).
Trans-cinnamaldehyde (TC), on the other hand, is a GRAS-status ingredient present
in the bark extract of cinnamon (Cinnamomum zeylandicum). Various studies have
demonstrated the antimicrobial properties of TC against both gram-negative and positive bacteria (Burt, 2004; Upadhyay et al., 2014).
Hepatic transcriptome studies using RNA-sequencing (RNA-Seq) in turkeys and
ducklings exposed to AFB1 have revealed differential expression in genes associated
with fatty acid, energy metabolism, detoxification, development, immunity, cell
proliferation, and cancer upon AF exposure (Yarru et al., 2009; Monson et al., 2014;
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Zhang et al., 2016). However, systematic and functional analysis of the hepatic
transcriptome in broiler chickens exposed to AF has not been reported. Therefore, the
objective of this study was to discover the altered response of the hepatic
transcriptome of chickens exposed to AF using high throughput RNA-seq. In addition,
to elucidate the potential mechanisms by which CR and TC protect liver from
aflatoxicosis in chickens, we determined the effect of in-feed supplementation of
these phytochemicals on the response of hepatic transcriptome to AF in broiler
chickens.
2. Materials and Methods
2.1 Animal samples
All experiments were approved by the Institutional Animal Care and Use
Committee (IACUC) at the University of Connecticut. Day-old broiler chicks (Ross x
Ross) were obtained from a commercial hatchery and randomly assigned to floor pens
provided with ad libitum feed, water, age-appropriate ambient temperatures, and
bedding at the Poultry Isolation Facility of the University of Connecticut.
A total of 240 chickens were randomly assigned to 6 different treatments with 20
birds per pen and two pens per treatment. The 6 treatment groups included: (1)
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Control (feed with no AF and no CR/TC supplementation), (2) CR control (feed with
no AF, but 0.75% supplemental CR), (3) TC control (feed with no AF, but 0.75%
supplemental TC), (4) AF (feed containing ~2.5 ppm AF), (5) AF+CR (feed
containing ~2.5 ppm AF and 0.75% supplemental CR), and (6) AF+TC (feed
containing ~2.5 ppm AF and 0.75% supplemental TC).
2.2 RNA isolation and sequencing
On week 3 of the experiment, liver samples of five chickens from each treatment
group were subjected to transcriptome analysis. Total RNA was isolated from each
chicken liver sample by TRIzol extraction (Ambion, Inc., Austin, TX, USA), followed
by DNAase-treatment (Turbo DNA-free kit, Ambion Inc., Austin, TX, USA), and the
samples were stored at -80oC. Spectrophotometry (Nanodrop 1000, Nanodrop
Technologies, Wilmington, DE, USA) was used for an initial assessment of RNA
concentration and quality. The RNA integrity of the samples was confirmed using
2100 Bioanalyzer (Agilent Technologist, Santa Clara, CA, USA), and only samples
that had an RNA integrity score (RIN) of above 7.0 was used for subsequent analyses.
All RNA samples had clear separation of 18S and 28S peaks on the
electropherograms. RNA samples (N=30; 5 samples per treatment) were submitted to
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University of Connecticut Center for Genome Innovation (UConn CGI) for library
preparation and sequencing. Indexed libraries were constructed with 1 µg of total
RNA/sample with the TruSeq RNA Sample Preparation Kit version 2 (Illumina Inc.,
San Diego, CA, USA). The libraries were multiplexed and sequenced on four flow
cell lanes on the NextSeg 500 (Illumina Inc., San Diego, CA, USA) to produce 2 x 75
bp paired-end reads.
2.3 Read trimming, dataset QC analysis, and mapping
For dataset trimming, sequences with low quality, containing adaptor sequences,
and less than 30 nucleotides were removed for further analysis. The quality of each
dataset before and after trimming was measured with FastQC program. The corrected
reads were aligned to a chicken reference genome using STAR aligner
genomeGenerate mode and the mapped reads were converted to read counts using
htseq-count (Gao et al., 2016).
2.4 Differential expression and functional analysis
The expression of each transcript in each treatment group was determined using
the R package DESeq2 following the standard workflow (Love et al., 2014). Read
counts were first fit to a model based on a negative binomial distribution and
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normalized by size-scaling for differences in library sequencing depth. Empirical
Bayes shrinkage estimates of dispersion and log2 fold change (log2FC) were
employed by DESeq2 to prevent over-dispersion, equalize the dynamic range of read
counts, handle variable sample sizes, and make log2FC reproducible. Differential
expression (DE) of genes between groups was then evaluated using normalized read
counts. Transcripts were considered to possess statistically significant DE if q-value
(FDR adjusted p-value based on the Benjamin-Hochberg procedure) was ≤ 0.05.
Expression in each treatment (CR control, TC control, AF, AF+CR, AF+TC) was
compared to control group to determine the impact of AF and/or phytochemicals. In
addition, AF+CR and AF+TC groups were also individually compared to the AF
group to determine the effect of CR and TC supplementation on chicken liver in the
presence of AF.
Principle component analysis (PCA) plots, MA plots, and heatmaps were created
in R studio by DESeq2 to visualize the expression data and the results of significance
testing, as previously described (Monson et al., 2014; Monson et al., 2015). For all
significant DE transcripts in each pair-wise comparison, gene pathways and
toxicological functions were investigated using Ingenuity Pathway Analysis (IPA)

147

(Ingenuity Systems, Redwood City, CA, USA).
3. Results
3.1 RNA-seq dataset
Total RNA isolated from chicken livers treated with or without AF in the
presence or absence of CR or TC (n=5/ treatment) was used for the construction of
individual barcoded libraries. RNA-seq libraries (30 libraries) were sequenced to
produce over 340 M paired reads (681 M total reads) totaling 36.8 Gb of raw
sequence data (Table 1). After mapping, one sample from AF group and one sample
from TC control group showed only 39% and 32% of uniquely mapped ratio to the
chicken reference, and 60.33% and 66.56% of the sequences were unmapped.
Therefore, these two samples were excluded for subsequent analyses. Approximately
79.9% of corrected sequence mapped uniquely to the annotate chicken gene set using
STAR aligner (Table 2). The percentage of genomic alignment was similar among the
groups (Control 84.9% ± 0.9; CR control 83.1% ± 1.7; TC control 82.1% ± 2.7; AF
76.6% ± 2.5; AF+CR 75.9% ± 3.4; AF+TC 77.2% ± 4.7; mean ± SEM), thereby
suggesting that there were no obvious detectable biases in the sequence data.
3.2 Sample variation
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Principle Component Analysis (PCA) was used to evaluate variations within and
between groups based on regularized log2 transformed read counts (Figure 1). The
principle component 1 (PC1) axis explained the greatest amount of the variation (39%)
and separated transcriptomic expression profiles between TC control and AF+TC.
Similarly, principle component 2 (PC2) axis indicated a 25% variance. Overall, this
distribution illustrates the difference between 6 treatment groups.
3.3 Differential expression (DE) analysis
When the treatment groups AF, AF+CR, and CR control were separately
compared to the control (AF/Control, AF+CR/Control, CR control/Control) using
DESeq2 package, a total of 507 genes were found to be significantly affected,
including 246 genes that were significantly up-regulated and 261 down-regulated
genes (Figure 2). Specifically, 185 genes were regulated (72 up-regulated and 113
down-regulated) by AF-treated group as compared to the control (AF/Control), and
348 genes (178 up-regulated and 170 down-regulated) were found to be affected in
AF+CR when compared to the control (AF+CR/Control). Three genes were in
common in these three groups (AF, AF+CR, and CR control), and AF/Control and
AF+CR/Control shared a total of 60 genes. Similarly, when the treatment groups AF,
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AF+TC, and TC control were compared to the control (AF/Control, AF+TC/Control,
and TC control/Control), respectively, expressions of 678 genes were found to be
significantly changed, of which 344 genes were up-regulated and 334 genes were
down-regulated. In addition, 548 genes (280 up-regulated and 268 down-regulated)
were significantly regulated in AF+TC/Control. Six genes were in common within
these 3 groups (AF/Control, AF+TC/Control, and TC control/Control), and 72 genes
were in common between AF/Control and AF+TC/Control.
Furthermore, we compared significant DE of AF+CR group to CR control group
(AF+CR/CR control) and AF+TC group to TC control group (AF+TC/TC control).
Results revealed that 130 genes were significantly up-regulated and 114 genes were
significantly down-regulated in AF+CR/CR control comparison. Likely, 260 genes
and 168 genes were found to be significantly up- and down- regulated AF+TC/TC
control. In addition, 15 genes were in common between AF+CR/AF and AF+CR/CR
control, and 118 genes were in common between AF+TC/AF and AF+TC/TC control
(Figure 3).
To visualize the distribution of the significant DE, log2 fold change was plotted
against mean normalized expression for each predicated transcript by comparing AF
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to control, AF+CR to AF, and AF+TC to AF (Figure 4). In addition, relative similarity
between the six treatment groups was expressed in the Heatmap (Figure 5). When the
top 1000 transcripts with highest expression level in each treatment were compared,
CR control and control groups were clustered and TC control group had the furthest
distance to control.
3.4 Functional analysis
3.4.1 Impact of AF
In the AF group, 38.9% of significant DE transcripts were up-regulated and
61.1% of significant DE transcripts were down-regulated when compared to control
(AF/Control). These significant DE transcripts in the AF group are involved in the
pathways associated with metabolism of lipid, hepatic diseases, inflammation of
organs, and apoptosis (Table 3-6). Specifically, compared to the control, 17 genes
associated with concentrations of lipids were regulated, including the up-regulation of
genes PXRG, PPARGC1A, SMARCD3, ACSL1, CREB3L3, and AHSG. In addition, 14
genes that are associated with the metabolism of lipids, including LSS, POR and
HMGCR genes were down-regulated. These results suggest an increase in lipid
accumulation and decrease in lipid metabolism in the AF-treated group as compared
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to the control.
In addition, 8 genes related to hepatic steatosis, including STAT3, EHHADH, and
LIPA genes were dysregulated in the AF/Control group. Moreover, 16 genes involved
in hepatocellular carcinoma demonstrated 44% up-regulation and 56% downregulation, where up-regulation of RRM2 gene in the AF-treated group as compared to
control has been used as a marker gene to identify hepatocellular carcinoma in
humans (Looi et al., 2008; Wang et al., 2010). Additionally, 21 genes are related to
inflammation of organs with 43% up-regulation and 57% down-regulation, and 11
genes out of the 21 genes are specifically associated with inflammation of lung,
including ABHD6, NBR1, HIF1A, and LIPA genes.
Apoptosis was also affected in the AF-treated group, where 29 genes with
significant DE were down-regulated in AF group when compared to control. Since
these genes are reported to decrease apoptosis, the down-regulation of these genes
suggested an increase of apoptosis due to AF exposure.
3.4.2 Effect of CR in the presence of AF
When we compared AF+CR group to the control (AF+CR/Control), 51% of the
genes were up-regulated and 49% of the genes were down-regulated. Although
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AF+CR/Control and AF/Control shared 60 genes (31 genes up-regulated and 29 genes
down-regulated), no significant difference in the expression of these 60 genes was
observed. Furthermore, we compared AF+CR group to AF group (AF+CR/AF) and
results showed that 64% of genes with significant DE were up-regulated and 36% of
genes were down-regulated. Out of these, four genes (GUCY2C, EPAS1, CAT, and
ACAA2) associated with decreasing hepatic steatosis were up-regulated, indicating a
decrease in hepatic steatosis in AF+CR when compared to AF-treated group (Table 7).
3.4.3 Effect of TC in the presence of AF
The results of AF+TC/AF showed 33% up-regulation and 67% down-regulation
of the genes with significant DE. Overall, 386 genes which had significant DE are
associated with mobility and mortality, organismal death, thermoregulation, oxidation
of fatty acids, and hepatic steatosis. Table 8 shows that 21 genes associated with
hepatic steatosis had significant DE when compared AF+TC to AF (AF+TC/AF), and
among these 14 up-regulated genes and 2 down-regulated genes demonstrated the
potential to decrease hepatic steatosis. In addition, 14 genes were found to affect
oxidation of fatty acids in AF+TC/AF, where 12 genes showed a trend to potentially
increase the oxidation of fatty acids (Table 9). Moreover, 23 up-regulated genes
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related to promote development are shown in Table 10 in AF+TC when compared to
AF.
3.4.4 Overall comparison
Differences in the pathways affected by AF and/or phytochemicals were also
highlighted by comparative pathway analysis in IPA (Figure 6). For example,
“LXR/PXR Activation” pathway was significant in AF, AF+CR, and AF+TC group,
whereas levels of gene down-regulation were not similar in these three groups (33.3%,
50%, and 100%, respectively). In addition, significant associations were made to the
“Fatty Acid Metabolism” pathway in all 4 groups versus control except TC
control/Control. In these comparisons (AF/Control, AF+CR/Control, AF+TC/Control
and CR control/Control), AF/Control had the highest ratio of down-regulation of the
genes (71%) in the “Fatty Acid Metabolism” pathway, followed by AF+CR/Control
(33%) and AF+TC/Control (33%). Moreover, “Increases Liver Hyperplasia/
Hyperproliferation” and “p53 Signaling” pathways were significantly affected in
AF/Control and AF+TC/Control, due to similar levels of down-regulation of genes in
the pathway.
4. Discussion

154

Liver is the primary organ of AF accumulation and metabolism, and it is also the
main site where AF metabolites bind with nucleic acids and proteins initiating its
toxicity (Monson et al., 2014). Consequently, ingestion of AF-contaminated feed
results in chicken aflatoxicosis affecting bird health and performance. Previously, we
observed that feed containing 2.5 ppm AF produced phenotypic effects in chickens,
including reduced chicken performance and enlarged relative weight of liver (Yin et
al., 2015b). However, in-feed supplementation of CR or TC minimized the AFinduced toxicity to chicken liver (Yin et al., 2015b). Therefore, in the present study,
we utilized RNA-seq technique to characterize gene expression responses to AF in the
hepatic transcriptome of broilers with or without in-feed supplementation of
phytochemicals (CR and TC).
4.1 Responses to AF
Intake of AF diet was hypothesized to result in gene expression changes in
chicken liver representing characteristic pathophysiology associated with aflatoxicosis
in chickens. RNA-seq results revealed that the expression of genes involved in some
specific pathways, including hepatic diseases, lipid metabolism, inflammation of
organs and apoptosis were altered in the hepatic transcriptome of chickens fed with
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2.5 ppm AF diet for 3 weeks.
The carcinogenic nature of AF in mammals is well established and chronic
exposure of AF constitutes a risk factor for hepatocellular carcinoma in humans
(Monson et al., 2014). In chickens, acute and chronic aflatoxicosis cause lesions in
liver, including bile duct proliferation/hyperplasia, fatty acid infiltration, and enlarged
hepatic cells (Yunus et al., 2011; Yin et al., 2015a). Adverse effects on liver from AF
exposure are likely caused by genes associated with cell cycle and apoptosis (Monson
et al., 2014). In the current study, several genes associated with apoptosis were
dysregulated. For instance, DHCR24 gene was down-regulated in AF-treated group
when compared to the control. Since high expression of DHCR24 protects melanoma
cells from apoptosis triggered by oxidative stress (Stasi et al., 2005), down-regulation
of this gene potentially favors apoptosis.
Surprisingly, genes known to encode enzymes for phase I detoxification of AF in
liver such as CYP3A4, CYP2A6, CYP1A1, and CYP1A2 were not significantly
regulated in AF group as compared to control (AF/Control) in the current study. In
mammals, CYP1A2 and CYP3A4 are capable of initiating the biotransformation of
AFB1 into toxic intermediate AF-8, 9-epoxide, or other forms such as aflatoxin M1,
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aflatoxin Q1, and other metabolites (Gallagher et al., 1996; Guengerich et al., 1996).
Our results concurred with the findings of Zhang et al. (2016), who while analyzing
the hepatic transcriptome of ducking liver under aflatoxicosis, observed that CYP
genes were not affected upon AF exposure. Likewise, Monson et al. (2014) studied
the hepatic transcriptome in turkeys exposed to AF and reported no expression
changes of CYP1A5 and CYP3A37 in the AF-treated group. However, Yarru et al.
(2009) by microarray analysis showed that CYP1A1 and CYP2H1, which are known
to metabolize various xenobiotic metabolites, were up-regulated in chicken liver due
to AF exposure (Yarru et al., 2009). Differences in the response of various poultry
species such as chickens, turkeys, ducklings, and quails to AF exposure have been
observed (Leeson et al., 1995; Diaz et al., 2010), and the biochemical basis for these
differences has not been well understood. Although AF biotransformation in
mammals is relatively well understood, in-depth studies in poultry are needed (Savlík
et al., 2007).
In this study, DE analysis of the chicken liver transcriptome identified several
genes associated with hepatocellular carcinoma in animals. For example, RRM2 gene,
which was up-regulated in the AF group as compared to the control group, is linked to
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increased hepatocellular carcinoma. RRM2 is a subunit of ribonucleotide reductase
that catalyzes the conversion of ribonucleotide 5’-diphoshphates into their
corresponding 2’-deoxyribonucleotides. Satow et al. (2010) confirmed that the
expression of RRM2 gene was increased in hepatocellular carcinoma patients and
potentially accelerated the proliferation of the cancer cells.
Dietary AFB1 exposure in poultry has been known to induce changes lipid
metabolism resulting in steatosis in the liver, which causes hepatomegaly and
increased liver weight relative to body weight (Eaton and Gallagher, 1994; Bedard
and Massey, 2006; Rawal and Coulombe, 2010). In addition, increased lipid content
in liver due to AF exposure often causes liver pigmentation to become pale or yellow
(Ortatatli and Oguz, 2001; Monson et al., 2015). In our study, multiple genes linked to
hepatic steatosis and lipid metabolism were found to be significantly affected. For
example, we observed a down-regulation of STAT3 genes, which potentially increase
hepatic steatosis. Inoue and coworkers (2004) reported that liver-specific STAT3
knockout increases hepatic triglyceride content in mouse and could eventually lead to
fatty liver. In addition, LIPA gene encoding lysosomal acidic lipase (LPL) that
hydrolyzes cholesteryl esters derived from cell internalization of plasma lipoproteins
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was also down-regulated in the liver of birds fed with 2.5 ppm AF. LPL is involved in
the breakdown of triglyceride in lipoproteins and is essential to lipid metabolism and
storage (Ahn et al., 2011).
Significant DE was identified for multiple genes involved in lipid regulation.
LSS, POR, HMGCR were significantly down-regulated in the AF group when
compared to the control (AF/Control), which might alleviate the accumulation of fat
vacuoles in liver. In addition, genes RXRG, PPARGC1A, SMARCD3, ACSL1,
CREB3L3, and AHSG were up-regulated indicating elevated concentrations of
acyglycerol, triacylglycerol, and lipids (Liu et al., 1999; Haugen et al., 2004; Lin et al.,
2004). The responses of these genes to AF exposure in chickens could be a response
to the increased retention of lipids in the liver (Monson et al., 2014). Similar gene
expression findings associated with fatty acid metabolism have been reported in
ducklings and turkeys through RNA-seq technique (Monson et al., 2014 and Zhang et
al., 2016).
4.2 Impact of phytochemicals
Previously, we observed that CR and TC supplementation in AF-contaminated
feed ameliorated AF-induced adverse effects in chickens (Yin et al., 2015b).
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Histological analysis also revealed that phytochemicals reduced AF-induced toxic
effects in the liver of birds fed with 2.5 ppm AF, where phytochemical-treated
chickens had decreased hepatocellular degeneration, necrosis, and inflammation in the
liver as compared to chickens fed with AF feed alone. In the present study, RNA-seq
analysis demonstrated changes in gene expression in the liver of chicken fed with CR
or TC and 2.5 ppm AF when compared to birds fed with AF alone. When we
compared significant DE transcripts in the AF+CR group to AF group (AF+CR/AF),
we observed a decrease of hepatic steatosis by up-regulating genes GUCY2C and
EPAS1 in the AF+CR group. GUCY2C is a transmembrane receptor that makes cyclic
guanosine monophosphate (cGMP) in response to paracrine hormones guanylin and
uroguanylin. According to Valentino et al. (2011), silencing of GUCY2C in mice
disrupts satiation, resulting in hyperphagia and subsequent obesity and metabolic
syndrome. Moreover, Scortegagna and coworkers (2003) reported that mice lacking
the HIF family member HIF-2-alpha encoded by EPAS1 show a syndrome of hepatic
steatosis and dysregulated fatty acid oxidation.
Further, significant DE analysis comparing AF+TC and AF groups (AF+TC/AF)
revealed that a total of 386 genes had significantly differed DE from the AF group,
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and these genes are associated with hepatic steatosis, oxidation of fatty acids,
development, organismal death, and thermoregulation. A total of 21 genes with
significant DE in AF+TC group as compared to control were involved in hepatic
steatosis. In addition, a substantial increase in expression was observed for LPIN1
gene, which encodes Lipin1, which has been shown to regulate cellular lipid
metabolism in liver (Finck et al., 2006). In the same study, Finck et al. (2006) also
observed that mice that lacked Lipin1 demonstrated hepatic steatosis LPIN1 serves as
a nuclear transcriptional co-activator in hepatocytes, where it interacts with a complex
containing proliferator-activated receptors (PPARα and PPARγ) to regulate the
expression of genes associated with fatty acid oxidation (Finck et al., 2006). In the
current study, we observed an increase in the expression for PPAR receptors,
PPARγ1α in AF+TC/AF, indicating an increase in fatty acid oxidation in chicken liver
exposed to AF with TC supplementation. Additionally, multiple genes associated with
development were found to be significantly up-regulated in AF+TC/Control,
suggesting greater body size with TC supplementation in the presence of AF
contamination. The phenotypic findings from our previous study also agree with the
significant DE analysis that in-feed supplementation of TC with 2.5 ppm AF
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increased body weight of birds when compared to birds fed with AF alone (Yin et al.,
2015b).
5. Conclusions
In this study, hepatic transcriptome analysis using RNA-seq characterized
pathways and genes associated with aflatoxicosis in chickens, including hepatic
steatosis, hepatic carcinoma, fatty acid metabolism, inflammation, and apoptosis. Infeed supplementation of CR and TC that phenotypically reduced AF-induced toxicity
in chicken liver also showed a trend of decreased hepatic steatosis at the gene level by
regulating the expression of associated genes when compared to AF. In addition,
genes with significant DE in AF+TC group as compared to control suggested an
increase in lipid oxidation and development. In summary, the current findings
demonstrated the first comparison of the responses of chickens to AF with or without
supplementation of phytochemicals, and delineated the potential mechanisms by
which these phytochemicals reduced aflatoxicosis in chickens. However, further
research on these major DE genes at the cellular level would be beneficial to validate
the RNA-seq results.

162

References:
Ahn, J., H. Lee, C. H. Chung, and T. Ha (2011). High fat diet induced downregulation
of microRNA-467b increased lipoprotein lipase in hepatic steatosis. Biochem biophy
res communi 414(4), 664-669.
Bedard, L. L., and T. E. Massey. (2006). Aflatoxin B 1-induced DNA damage and its
repair. Cancer letters 241(2), 174-183.
Bintvihok, A., S. Thiengnin, K. Doi, and S. Kumagai. (2002) Residues of aflatoxins
in the liver, muscle and eggs of domestic fowls. J Vet Sci Med Diagn 64:1037-1039.
Burt, S. 2004. Essential oils: their antibacterial properties and potential application in
foods: a review. Int. J Food Microbiol 94:223-253.
CAST. (1989) Mycotoxins: economic and health risks. Council for Agricultural
Science and Technology, 137 Lynn Avenue, Ames, IA 50010.
Diaz, G. J., H. W. Murcia, and S. M. Cepeda. (2010). Cytochrome P450 enzymes
involved in the metabolism of aflatoxin B1 in chickens and quail. Poul Sci 89(11),
2461-2469.
Eaton, D. L., and E. P. Gallagher. (1994). Mechanisms of aflatoxin carcinogenesis.
Annu Rev Pharmacol Toxicol. 34(1), 135-172.
Finck, B. N., M. C. Gropler, Z. Chen, T. C. Leone, M. A. Croce, T. E. Harris, and D. P.
Kelly. (2006). Lipin 1 is an inducible amplifier of the hepatic PGC-1α/PPARα
regulatory pathway. Cell metabolism 4(3), 199-210.
Gallagher, E. P., K. L. Kunze, P. L. Stapleton, and D. L. Eaton. (1996). The Kinetics
of Aflatoxin B1Oxidation by Human cDNA-Expressed and Human Liver Microsomal
Cytochromes P450 1A2 and 3A4. Toxicol Appl pharmacol 141(2), 595-606.

163

Gao, C., I. C. McDowell, S. Zhao, C. D. Brown, and B. E. Engelhardt. (2016).
Context Specific and Differential Gene Co-expression Networks via Bayesian
Biclustering. PLoS Comput Biol 12(7), e1004791.
Guengerich, F. P., W. W. Johnson, Y. F. Ueng, H. Yamazaki, and T. Shimada. (1996).
Involvement of cytochrome P450, glutathione S-transferase, and epoxide hydrolase in
the metabolism of aflatoxin B1 and relevance to risk of human liver cancer. Environ
Health Persp 104(Suppl 3), 557.
Haugen, B. R., D. R. Jensen, V. Sharma, L. K. Pulawa, W. R. Hays, W. Krezel, and R.
H. Eckel. (2004). Retinoid X receptor γ-deficient mice have increased skeletal muscle
lipoprotein lipase activity and less weight gain when fed a high-fat diet. Endocrinol
145(8), 3679-3685.
Hsu, I. C., R. A. Metcalf, T. Sun, J. A. Welsh, N. J. Wang, and C. C. Harris (1991).
Mutational hot spot in the p53 gene in human hepatocellular carcinomas. Nature,
350(6317), 427-428.
Inoue, H., W. Ogawa, M. Ozaki, S. Haga, M. Matsumoto, K. Furukawa, and K.
Teshigawara. (2004). Role of STAT-3 in regulation of hepatic gluconeogenic genes
and carbohydrate metabolism in vivo. Nature medicine 10(2), 168-174.
Leeson, S., G. Diaz, and J. D. Sumers. (1995) Aflatoxins. Page 249-298 in Poultry
Metabolic Disorders and Mycotoxins. Leeson S., J. D. G. Gonzala, and J. D. Sumer,
ed. Guelph, Canada.
Lin, J., P. H. Wu, P. T. Tarr, K. S. Lindenberg, J. St-Pierre, C. Y. Zhang, and L. Cui.
(2004). Defects in adaptive energy metabolism with CNS-linked hyperactivity in
PGC-1α null mice. Cell 119(1), 121-135.
Liu, S., C. Croniger, C. Arizmendi, M. Harada-Shiba, J. Ren, V. Poli, J. E. Friedman.
(1999). Hypoglycemia and impaired hepatic glucose production in mice with a
deletion of the C/EBPβ gene. J Clin Invest 103(2), 207-213.

164

Love, M. I., W. Huber, and S. Anders. (2014). Moderated estimation of fold change
and dispersion for RNA-seq data with DESeq2. Genome biol 15(12), 550.
Monson, M. S., R. E. Settlage, K. W. McMahon, K. M. Mendoza, S. Rawal, H. S. ElNezami, R. A. Coulombe, and K. M. Reed (2014). Response of the hepatic
transcriptome to aflatoxin B 1 in domestic turkey (Meleagris gallopavo). Plos one
9(6), e100930.
Monson, M. S., R. E. Settlage, K. M. Mendoza, S. Rawal, H. S. El-Nezami, R. A.
Coulombe, and K. M. (2015). Modulation of the spleen transcriptome in domestic
turkey (Meleagris gallopavo) in response to aflatoxin B1 and probiotics.
Immunogenetics 67(3), 163-178.
Oguz, H., T. Kececi, Y. O. Birdane, F. Onder, and V. Kurtoglu. (2000) Effect of
clinoptilolite on serum biochemical and haematological characters of broiler chickens
during aflatoxicosis. Res in Vet Sci 69:89-93.
Oguz, H. (2011) A review from experimental trials on detoxification of aflatoxin in
poultry feed. Eurasian J Vet Sci 27:1-12.
Ortatatli, M., and H. Oğuz. (2001). Ameliorative effects of dietary clinoptilolite on
pathological changes in broiler chickens during aflatoxicosis. Res Vet Res 71(1), 5966.
Qureshi, M. A., J. Brake, P. B. Hamilton, W. M. Hagler, and S. Nesheim. (1998)
Dietary exposure of breeders to aflatoxin results in immune dysfunction in progeny
chicks. Poult Sci 77:812-819.
Rawal, S., J. E. Kim, and R. Coulombe. (2010). Aflatoxin B 1 in poultry: toxicology,
metabolism and prevention. Res Vet Sci 89(3), 325-331.
Satow, R., M. Shitashige, Y. Kanai, F. Takeshita, H. Ojima, T. Jigami, and T.
Yamada (2010). Combined functional genome survey of therapeutic targets for
hepatocellular carcinoma. Clinical Cancer Res 16(9), 2518-2528.
165

Šavlík, M., L. Poláčková, B. Szotáková, J. Lamka, J. Velík, and L. Skálová. (2007).
Activities of biotransformation enzymes in pheasant (Phasianus colchicus) and their
modulation by in vivo administration of mebendazole and flubendazole. Res Vet Sci
83(1), 20-26.
Scortegagna, M., K. Ding, Y. Oktay, A. Gaur, F. Thurmond, L. J. Yan, and M. J.
Bennett. (2003). Multiple organ pathology, metabolic abnormalities and impaired
homeostasis of reactive oxygen species in Epas1−/− mice. Nature genetics 35(4), 331340.
Sur, E. and I. Celik. (2003) Effects of aflatoxin B1 on the development of the bursa of
Fabricius and blood lymphocyte acid phosphatase of the chicken. Br Poult Sci
44:558-566.
Tessari, E. N. C., C. A. F. Oliveira, A. L. S. P. Cardoso, D. R. Ledoux, and G. E.
Rottinghaus. (2006) Effects of aflatoxin B1 and fumonisin B1 on body weight,
antibody titres and histology of broiler chicks. Br Poult Sci 47:357-364.
Upadhyaya, I., A. Kollanoor-Johny, M. J. Darre, and K. Venkitanarayanan. (2014)
Efficacy of plant-derived antimicrobials for reducing egg-borne transmission of
Salmonella Enteritidis. J Appl Poul Res 23.2:330-339
Valentino, M. A., J. E. Lin, A. E. Snook, P. Li, G. W. Kim, G. Marszalowicz, and S. A.
Waldman. (2011). A uroguanylin-GUCY2C endocrine axis regulates feeding in mice.
J Clin Inves 121(9), 3578-3588.
Yarru, L. P., R. S. Settivari, N. K. S. Gowda, E. Antoniou, D. R. Ledoux, and G. E.
Rottinghaus. (2009). Effects of turmeric (Curcuma longa) on the expression of hepatic
genes associated with biotransformation, antioxidant, and immune systems in broiler
chicks fed aflatoxin. Poul Sci 88(12), 2620-2627.
Yin, H. B., Chen, C. H., Kollanoor-Johny, A., Darre, M. J., and Venkitanarayanan, K.
(2015a) Controlling Aspergillus flavus and Aspergillus parasiticus growth and
166

aflatoxin production in poultry feed using carvacrol and trans-cinnamaldehyde. Poul
Sci pev207.
Yin, H. B., C. H. Chen, I. Upadhyaya, A. Upadhyaya, S. Fancher, S., J. Li, M. S. Nair,
S. Mooyottu, M. I. Khan, M. J. Darre, A. M. Donoghue, D. J. Donoghue, and K.
Venkitanarayanan. (2015b, July). Efficacy of in-feed supplementation of plant-derived
antimicrobials in reducing aflatoxicosis in chickens. In Meeting Abstract (Vol. 94, No.
9).
Yunus, A. W., E. Razzazi-Fazeli, and J. Bohm. (2011) Aflatoxin B1 in affecting
broiler’s performance, immunity, and gastrointestinal tract: a review of history and
contemporary issues. Toxins 3:566-590.
Zhang, N. Y., M. Qi, X. Gao, L. Zhao, J. Liu, C. Q. Gu, and D. S. Qi. (2016).
Response of the hepatic transcriptome to aflatoxin B 1 in ducklings. Toxicon 111, 6976.

167

Table 1. Summary of the RNA-seq datasets1.
Total reads

Total paired
reads

AF1

23040611.6

11520305.8

Total paired
reads after
trimming
20065849.2

AF+CR2

22296719.2

11148359.6

AF+TC3

22912180

Control

4

CR
control5
TC
control6

Total single reads
after trimming

Total discarded
paired reads

Total discarded
single reads

1373625.6

227511.2

1373625.6

19420677.6

1314987.4

246066.8

1314987.4

11456090

20412432.4

1159848

180051.6

1159848

24870774.8

12435387.4

22707531.2

993746.4

175750.8

993746.4

23678286.8

11839143.4

21261222.4

1121186.8

174690.8

1121186.8

19403490.8

9701745.4

17463239.6

901513

137225.2

901513

1 Treatments

include Control: feed with no AF and no CR/TC supplementation; CR control: 0.75%

carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; AF: 2.5 ppm aflatoxins;

AF+CR: 2.5 ppm aflatoxins + 0.75% carvacrol; AF+TC: 2.5 ppm aflatoxins + 0.75% trans-

cinnamaldehyde.
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Table 2. Summary of the sequence mapping1.

1

Average input length

Mapped reads

Mapped (%)

Unmapped (%)

AF

145

7079017

76.575

22.1

AF+CR

145

7462495

75.942

22.75

AF+TC

146

7922860.8

77.242

21.596

Control

146

9338607

82.112

16.444

CR control

146.

8854640.6

83.112

15.406

TC control

146

7755954.8

84.905

13.68

Treatments include Control: feed with no AF and no CR/TC supplementation; CR control: 0.75%

carvacrol control; TC control: 0.75% trans-cinnamaldehyde control; AF: 2.5 ppm aflatoxins;

AF+CR: 2.5 ppm aflatoxins + 0.75% carvacrol; AF+TC: 2.5 ppm aflatoxins + 0.75% trans-

cinnamaldehyde.
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Table 3. Differentially expressed genes associated with lipid metabolism in liver of
chicken exposed to AF compared with control birds at the end of 21-d treatment
period (AF/Control).
Concentrations of Lipids
Transcript ID

Log2 FC1

Gene Symbol

Gene Name

ENSGALG00000003406

0.804

RXRG

Retinoid X receptor gamma

ENSGALG00000014398

0.781

PPARGC1A

PPARG coactivator 1 alpha

ENSGALG00000013049

0.601

SMARCD3

ENSGALG00000010628

0.587

ACSL1

SWI/SNF related, matrix associated, actin dependent
regulator of chromatin, subfamily d, member 3
Acyl-CoA synthetase long-chain family member 1

ENSGALG00000001252

0.584

CREB3L3

cAMP responsive element binding protein 3 like 3

ENSGALG00000008601

0.509

AHSG

Alpha 2-HS glycoprotein

ENSGALG00000008014

0.475

CEBPB

CCAAT/enhancer binding protein beta

ENSGALG00000003267

-0.391

STAT3

Signal transducer and activator of transcription 3

ENSGALG00000011870

-0.573

HIF1A

Hypoxia inducible factor 1 alpha subunit

ENSGALG00000006378

-0.666

LIPA

Lipase A, lysosomal acid type

ENSGALG00000002053

-0.698

POR

Cytochrome p450 oxidoreductase

ENSGALG00000006211

-0.743

BCL2L1

BCL2 like 1

ENSGALG00000015998

-0.777

PTDSS1

Phosphatidylserine synthase 1

ENSGALG00000011801

0.705

ESR2

Estrogen receptor 2

ENSGALG00000006680

-0.441

EHHADH

Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase

ENSGALG00000014948

-0.849

HMGCR

3-hydroxy-3-methylglutaryl-CoA reductase

ENSGALG00000002747

-1.007

FASN

Fatty acid synthase

Metabolism of Lipids
Transcript ID

Log2 FC1

Gene Symbol

Gene Name

ENSGALG00000005696

1

ABHD6

Abhydrolase domain containing 6

ENSGALG00000004106

-0.576

DHCR7

7-dehydrocholesterol reductase

ENSGALG00000006198

-0.59

LSS

Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)

ENSGALG00000009988

-0.626

ELOVL1

ELOVL fatty acid elongase 1

ENSGALG00000006378

-0.666

LIPA

Lipase A, lysosomal acid type

ENSGALG00000002053

-0.698

POR

Cytochrome p450 oxidoreductase

ENSGALG00000015998

-0.777

PTDSS1

Phosphatidylserine synthase 1

ENSGALG00000012834

-0.834

AKR1D1

Aldo-keto reductase family 1, member D1

ENSGALG00000009365

-0.841

CYP51A1

Cytochrome P450 family 51 subfamily A member 1

ENSGALG00000014948

-0.849

HMGCR

3-hydroxy-3-methylglutaryl-CoA reductase

ENSGALG00000007493

-0.902

NSDHL

NAD(P) dependent steroid dehydrogenase-like

ENSGALG00000016331

-0.997

SQLE

Squalene epoxidase

ENSGALG00000002747

-1.007

FASN

Fatty acid synthase

ENSGALG00000010792

-1.114

AGMO

Alkylglycerol monooxygenase

ENSGALG00000010798

-1.266

DHCR24

24-dehydrocholesterol reductase

1

FC: fold change.

170

Table 4. Differentially expressed genes associated with hepatic diseases in liver of
chicken exposed to AF compared with control birds at the end of 21-d treatment
period (AF/Control).
Hepatic steatosis
Transcript ID

Log2 FC

ENSGALG00000014398

1

Gene Symbol

Gene Name

0.781

PPARGC1A

PPARG coactivator 1 alpha

ENSGALG00000010628

0.587

ACSL1

Acyl-CoA synthetase long-chain family member 1

ENSGALG00000003267

-0.391

STAT3

Signal transducer and activator of transcription 3

ENSGALG00000006680

-0.441

EHHADH

Enoyl-CoA, hydratase/3-hydroxyacyl CoA dehydrogenase

ENSGALG00000006378

-0.666

LIPA

Lipase A, lysosomal acid type

ENSGALG00000002053

-0.698

POR

Cytochrome p450 oxidoreductase

ENSGALG00000014948

-0.849

HMGCR

3-hydroxy-3-methylglutaryl-CoA reductase

ENSGALG00000002747

-1.007

FASN

Fatty acid synthase

Hepatocellular carcinoma
Transcript ID

Log2 FC

ENSGALG00000010469

1

Gene Symbol

Gene Name

0.998

CYP4A22

Cytochrome P450 family 4 subfamily A member 22

ENSGALG00000016442

0.964

RRM2

Ribonucleotide reductase regulatory subunit M2

ENSGALG00000014627

0.622

FRMD4B

FERM domain containing 4B

ENSGALG00000001252

0.584

CREB3L3

cAMP responsive element binding protein 3 like 3

ENSGALG00000004477

0.564

NCOR1

Nuclear receptor corepressor 1

ENSGALG00000021399

0.537

ABCA8

ATP binding cassette subfamily A member 8

ENSGALG00000011811

0.511

SYNE2

Spectrin repeat containing nuclear envelope protein 2

ENSGALG00000011870

-0.573

HIF1A

Hypoxia inducible factor 1 alpha subunit

ENSGALG00000001718

-0.646

CCNG1

Cyclin G1

ENSGALG00000002053

-0.698

POR

Cytochrome p450 oxidoreductase

ENSGALG00000006211

-0.743

BCL2L1

BCL2 like 1

ENSGALG00000012834

-0.834

AKR1D1

Aldo-keto reductase family 1, member D1

ENSGALG00000008551

-0.847

CRELD2

Cysteine rich with EGF like domains 2

ENSGALG00000003678

-0.896

GLUL

Glutamate-ammonia ligase

ENSGALG00000003879

-0.946

MFSD2A

Major facilitator superfamily domain containing 2A

ENSGALG00000016331

-0.997

SQLE

Squalene epoxidase

1

FC: fold change.
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Table 5. Differentially expressed genes associated with inflammation of organs in
liver of chicken exposed to AF compared with control birds at the end of 21-d
treatment period (AF/Control).
Inflammation of organs
Transcript ID

Log2 FC

ENSGALG00000005696

1

Gene Symbol

Gene Name

1

ABHD6

Abhydrolase domain containing 6

ENSGALG00000016442

0.964

RRM2

Ribonucleotide reductase regulatory subunit M2

ENSGALG00000003406

0.804

RXRG

Retinoid X receptor gamma

ENSGALG00000014398

0.781

PPARGC1A

PPARG coactivator 1 alpha

ENSGALG00000027907

0.648

NR2F1

Nuclear receptor subfamily 2 group F member 1

ENSGALG00000014627

0.622

FRMD4B

FERM domain containing 4B

ENSGALG00000013992

0.54

VNN1

Vanin 1

ENSGALG00000011811

0.511

SYNE2

Spectrin repeat containing nuclear envelope protein 2

ENSGALG00000002765

0.401

NBR1

NBR1, autophagy cargo receptor

ENSGALG00000003267

-0.391

STAT3

Signal transducer and activator of transcription 3

ENSGALG00000009621

-0.428

ACTB

Actin beta

ENSGALG00000014971

-0.477

SLC2A9

Solute carrier family 2 member 9

ENSGALG00000014140

-0.558

ARFGAP3

ADP ribosylation factor GTPase activating protein 3

ENSGALG00000011870

-0.573

HIF1A

Hypoxia inducible factor 1 alpha subunit

ENSGALG00000006378

-0.666

LIPA

Lipase A, lysosomal acid type

ENSGALG00000002053

-0.698

POR

Cytochrome p450 oxidoreductase

ENSGALG00000001000

-0.723

HSPA5

Heat shock protein family A (Hsp70) member 5

ENSGALG00000012834

-0.834

AKR1D1

Aldo-keto reductase family 1, member D1

ENSGALG00000009365

-0.841

CYP51A1

Cytochrome P450 family 51 subfamily A member 1

ENSGALG00000014948

-0.849

HMGCR

3-hydroxy-3-methylglutaryl-CoA reductase

ENSGALG00000006211

-0.743

BCL2L1

BCL2 like 1

1

FC: fold change.
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Table 6. Differentially expressed genes associated with cell apoptosis in liver of
chicken exposed to AF compared with control birds at the end of 21-d treatment
period (AF/Control).
Apoptosis
Transcript ID

Log 2 FC

ENSGALG00000005622

1

Symbol

Gene Name

-0.515

ARF4

ADP ribosylation factor 4

ENSGALG00000006211

-0.743

BCL2L1

BCL2 like 1

ENSGALG00000001718

-0.646

CCNG1

Cyclin G1

ENSGALG00000010798

-1.266

DHCR24

24-dehydrocholesterol reductase

ENSGALG00000010401

-0.47

EIF2A

Eukaryotic translation initiation factor 2A

ENSGALG00000028828

-0.48

EIF4E

Eukaryotic translation initiation factor 4E

ENSGALG00000001811

-0.581

EIF6

Eukaryotic translation initiation factor 6

ENSGALG00000002747

-1.007

FASN

Fatty acid synthase

ENSGALG00000000947

-1.054

FKBP5

FK506 binding protein 5

ENSGALG00000011870

-0.573

HIF1A

Hypoxia inducible factor 1 alpha subunit

ENSGALG00000012726

-0.752

HSP90B1

Heat shock protein 90 beta family member 1

ENSGALG00000001000

-0.723

HSPA5

Heat shock protein family A (Hsp70) member 5

ENSGALG00000017077

-0.964

HSPH1

Heat shock protein family H (Hsp110) member 1

ENSGALG00000007659

-0.757

HYOU1

Hypoxia up-regulated 1

ENSGALG00000027374

-1.119

KLF9

Kruppel like factor 9

ENSGALG00000006378

-0.666

LIPA

Lipase A, lysosomal acid type

ENSGALG00000026900

-0.631

LYPLA1

Lysophospholipase I

ENSGALG00000009782

-0.498

NAA15

N(alpha)-acetyltransferase 15, NatA auxiliary subunit

ENSGALG00000021658

-0.65

PAFAH2

Platelet activating factor acetylhydrolase 2

ENSGALG00000002053

-0.698

POR

Cytochrome p450 oxidoreductase

ENSGALG00000016162

-0.793

PTP4A3

Protein tyrosine phosphatase type IVA, member 3

ENSGALG00000001435

-0.833

SDF2L1

Stromal cell derived factor 2 like 1

ENSGALG00000004701

-0.361

SET

SET nuclear proto-oncogene

ENSGALG00000007251

-0.536

SIRT7

Sirtuin 7

ENSGALG00000015916

-0.599

SLC17A5

Solute carrier family 17 m ember 5

ENSGALG00000003267

-0.391

STAT3

Signal transducer and activator of transcription 3

ENSGALG00000013837

-0.589

TBL1XR1

Transducin (beta)-like 1 X-linked receptor 1

ENSGALG00000016651

-0.761

Tdh

L-threonine dehydrogenase

ENSGALG00000012585

-0.638

UBQLN1

Ubiquilin 1

1

FC: fold change.
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Table 7. Differentially expressed genes associated with hepatic steatosis in liver of
chicken exposed to AF with CR supplementation compared with birds fed with AF
alone at the end of 21-d treatment period (AF+CR/AF).
Hepatic steatosis
Transcript ID

Log2 FC

ENSGALG00000011838

1

Gene Symbol

Gene Name

1.448

GUCY2C

Guanylate Cyclase 2C

ENSGALG00000010005

0.922

EPAS1

Endothelial PAS Domain Protein 1

ENSGALG00000014471

0.856

CAT

Catalase

ENSGALG00000002777

0.567

ACAA2

Acetyl-CoA Acyltransferase 2

1

FC: fold change.
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Table 8. Differentially expressed genes associated with hepatic steatosis in liver of
chicken exposed to AF with TC supplementation compared with birds fed with AF
alone at the end of 21-d treatment period (AF+TC/AF).
Hepatic steatosis
Transcript ID

Log2 FC

ENSGALG00000002159

0.770

ENSGALG00000002479
ENSGALG00000002891

1

Gene Symbol

Gene Name

ACOX1

Acyl-CoA Oxidase 1

0.636

MAT1A

Methionine Adenosyltransferase 1A

0.461

ACADL

Acyl-CoA Dehydrogenase

ENSGALG00000003267

0.494

STAT3

Signal transducer and activator of transcription 3

ENSGALG00000003579

0.874

INSR

Insulin Receptor

ENSGALG00000005992

1.067

PDE8A

Phosphodiesterase 8A

ENSGALG00000006534

1.315

PEX11A

Peroxisomal Biogenesis Factor 11 Alpha

ENSGALG00000006680

0.783

EHHADH

ENSGALG00000007636

4.230

PCK1

Enoyl-CoA Hydratase And 3-Hydroxyacyl CoA
Dehydrogenase
Phosphoenolpyruvate Carboxykinase 1

ENSGALG00000008202

0.680

NR1H3

Nuclear Receptor Subfamily 1 Group H Member 3

ENSGALG00000011110

-1.349

DPP4

Dipeptidyl peptidase-4

ENSGALG00000011558

1.158

LRP6

LDL Receptor Related Protein 6

ENSGALG00000012437

1.828

IGFBP1

insulin-like growth factor-binding protein 1

ENSGALG00000012748

-1.043

ELOVL2

ELOVL Fatty Acid Elongase 2

ENSGALG00000014398

1.296

PPARGC1A

PPARG Coactivator 1 Alpha

ENSGALG00000016456

2.578

LPIN1

Lipin 1

ENSGALG00000016839

1.638

IRS2

Insulin Receptor Substrate 2

ENSGALG00000017394

1.254

INSIG1

Insulin Induced Gene 1

ENSGALG00000023435

-1.652

GATM

Glycine Amidinotransferase

ENSGALG00000023806

1.429

PITPNA

Phosphatidylinositol Transfer Protein Alpha

ENSGALG00000026207

1.403

CNTF

Ciliary Neurotrophic Factor

1

FC: fold change.
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Table 9. Differentially expressed genes associated with oxidation of fatty acids in
liver of chicken exposed to AF with TC supplementation compared with birds fed
with AF alone at the end of 21-d treatment period (AF+TC/AF).
Oxidation of Fatty Acids
Transcript ID

Log2 FC

ENSGALG00000002159

1

Gene Symbol

Gene Name

0.770

ACOX1

Acyl-CoA Oxidase 1

ENSGALG00000002891

0.461

ACADL

Acyl-CoA Dehydrogenase

ENSGALG00000003579

0.874

INSR

Insulin Receptor

ENSGALG00000006471

1.319

SLCO2A1

ENSGALG00000006680

0.783

EHHADH

ENSGALG00000007077

1.507

CPT1A

Solute Carrier Organic Anion Transporter Family
Member 2A1
Enoyl-CoA Hydratase And 3-Hydroxyacyl CoA
Dehydrogenase
Carnitine Palmitoyltransferase 1A

ENSGALG00000009505

0.882

PNPLA8

Patatin Like Phospholipase Domain Containing 8

ENSGALG00000009700

1.887

PDK4

Pyruvate Dehydrogenase Kinase 4

ENSGALG00000010769

0.836

HPGD

Hydroxyprostaglandin Dehydrogenase 15-(NAD)

ENSGALG00000012809

0.676

ECI2

Enoyl-CoA Delta Isomerase 2

ENSGALG00000013890

0.819

MC5R

Melanocortin 5 Receptor

ENSGALG00000014398

1.296

PPARGC1A

PPARG Coactivator 1 Alpha

ENSGALG00000016456

2.578

LPIN1

Lipin 1

ENSGALG00000016839

1.638

IRS2

Insulin Receptor Substrate 2

1

FC: fold change.
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Table 10. Differentially expressed genes associated with size of body in liver of
chicken exposed to AF with TC supplementation compared with birds fed with AF
alone at the end of 21-d treatment period (AF+TC/AF).
Development
Transcript ID

Log2 FC

ENSGALG00000000231

1

Gene Symbol

Gene Name

0.506

BNIP3L

BCL2/Adenovirus E1B 19kDa Interacting Protein 3-Like

ENSGALG00000002159

0.770

ACOX1

Acyl-CoA Oxidase 1

ENSGALG00000003579

0.874

INSR

Insulin Receptor

ENSGALG00000003879

1.117

MFSD2A

Major Facilitator Superfamily Domain Containing 2A

ENSGALG00000004122

0.596

PNRC2

Proline Rich Nuclear Receptor Coactivator 2

ENSGALG00000004288

1.251

HDAC4

Histone Deacetylase 4

ENSGALG00000004460

0.725

FOXK1

Forkhead Box K1

ENSGALG00000005095

1.853

SLC25A25

Solute Carrier Family 25 Member 25

ENSGALG00000005332

1.411

CACNA1D

Calcium Voltage-Gated Channel Subunit Alpha1 D

ENSGALG00000005541

0.952

GJB1

Gap Junction Protein Beta 1

ENSGALG00000005553

0.998

NLGN3

Neuroligin 3

ENSGALG00000007636

4.230

PCK1

Phosphoenolpyruvate Carboxykinase 1

ENSGALG00000007870

0.817

SMAD3

SMAD Family Member 3

ENSGALG00000008097

0.907

Celf1

Elav-Like Family Member 1

ENSGALG00000008701

1.681

XDH

Xanthine Dehydrogenase

ENSGALG00000009505

0.882

PNPLA8

Patatin Like Phospholipase Domain Containing 8

ENSGALG00000013867

1.724

PTPN2

Protein Tyrosine Phosphatase, Non-Receptor Type 2

ENSGALG00000014398

1.296

PPARGC1A

PPARG Coactivator 1 Alpha

ENSGALG00000015472

0.772

CHD7

Chromodomain Helicase DNA Binding Protein 7

ENSGALG00000015775

1.419

UBE2J1

Ubiquitin Conjugating Enzyme E2 J1

ENSGALG00000016839

1.638

IRS2

Insulin Receptor Substrate 2

ENSGALG00000017394

1.254

INSIG1

Insulin Induced Gene 1

ENSGALG00000023806

1.429

PITPNA

Phosphatidylinositol Transfer Protein Alpha

1

FC: fold change.
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Figure 1. Principle component analysis (PCA). PCA was performed on regularized
log2 transformed read counts in DESeq2. Principle component 1 (PC1) and principle
component 2 (PC2) explain 64% of the variation in read counts. Samples are plotted
by group: AF (aflatoxin; red), AF+CR (aflatoxin + carvacrol; brown), AF+TC
(aflatoxin + trans-cinnamaldehyde; green), Control (light blue), CR control (carvacrol
control; dark blue), TC control (trans-cinnamaldehyde control; pink).
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Figure 2. Liver transcripts with significant differential expression (DE) in each
comparison between treatment groups. Numbers in each section indicate predicted
transcripts with significant DE (q value < 0.05) that are shared between or unique to
each comparison. ↑ indicates the up-regulated transcripts and ↓ indicates downregulated transcripts. The total number of significant transcripts for each comparison
is shown beside the corresponding circle. This figure shows transcripts with
significant DE when compared to the control group.
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Figure 3. Liver transcripts with significant differential expression (DE) in each intertreatment comparison. Numbers in each section indicate predicted transcripts with
significant DE (q value < 0.05) that are shared between or unique to each comparison.
↑ indicates the up-regulated transcripts and ↓ indicates down-regulated transcripts.
This figure shows transcripts with significant DE in inter-treatment comparisons
(AF+CR/AF: Compared AF+CR group to AF group; AF+CR/CR control: Compared
AF+CR group to CR control group; AF+TC/AF: Compared AF+TC group to AF
group; AF+TC/TC control: Compared AF+TC group to TC control group)
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Figure 4. Relationship between mean expression and log2 fold change in each
comparison between treatment groups. Log2 fold change was plotted against the mean
normalized read counts for each predicted transcript with non-zero expression values
in each comparison between treatment groups. As determined in DESeq2, transcripts
with significant differential expression (DE) are highlighted in red (q-values < 0.05).
(4A) AF/Control; Compared AF group to the control (4B) AF+CR/AF; Compared
AF+CR group to AF (4C) AF+TC/AF; Compared AF+TC group to AF.
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Figure 5. Comparative expression of selected transcripts across all six treatment
groups. Heatmap was generated from variance stabilized and normalized read counts
using DESeq2 across aflatoxin (AF), aflatoxin + carvacrol (AF+CR), aflatoxin +
trans-cinnamaldehyde (AF+TC), control, carvacrol control (CR control), and transcinnamaldehyde control (TC control).
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Figure 6. Significant pathways associations vary in comparison of each treatment to
control. In each pair-wise comparison, Ingenuity Pathway Analysis (IPA) assigned pvalues to canonical pathways based on differential expression (DE). Bar plot provides
5 example pathways with variable significance between the AF (aflatoxin group; dark
blue), AF+CR (aflatoxin + carvacrol; bright blue), AF+TC (aflatoxin + transcinnamaldehyde; light blue), CR control (carvacrol control; black) and TC control
(trans-cinnamaldehyde control; grey). Pathway associations must have a –log(p-value)
> 1.3 (threshold, vertical yellow line) to be considered significant.
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Chapter VII
Summary
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Mycotoxins are toxic secondary metabolites that are capable of causing disease
and death in both animals and humans. The Food and Agriculture Organization (FAO)
reported that 25% of the world’s grains are contaminated by mycotoxins; aflatoxin
(AF) contamination is the most common among them. Aflatoxins (AF) are toxic,
mutagenic, and carcinogenic compounds produced by molds, Aspergillus flavus and
Aspergillus parasiticus, which can frequently contaminate feed ingredients such as
peanuts, corn, and cottonseed and cause aflatoxicosis in animals and humans.
Aflatoxicosis in poultry due to ingestion of AF contaminated feed negatively
affects chicken production parameters, causing severe economic losses to the poultry
industry. Specifically, dietary exposure to AF leads to decreased body weight, feed
intake, and efficiency of nutrient usage. In addition, AF residues in poultry products
pose a significant health hazard to humans. Thus, it is critical to develop scientifically
validated strategies for controlling AF in poultry feed and aflatoxicosis in chickens to
protect public health, bird health, and to ensure the financial sustainability of the
poultry industry.
This dissertation investigated the efficacy of two natural plant-derived
antimicrobials, namely carvacrol (CR) and trans-cinnamaldehyde (TC), for
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controlling aflatoxicosis in chickens. The first objective investigated the effect of CR
and TC on A. flavus and A. parasiticus growth, AF production, and expression of
toxin production genes in a broth system and in chicken feed during long-term storage.
Results revealed that CR and TC significantly inhibited A. flavus and A. parasiticus
growth and AF production in both broth system (P < 0.05) and in chicken feed during
the entire storage period (P < 0.05). All the concentrations of CR and TC decreased
AF concentrations in the feed to levels below the FDA regulated limit (20 ppb).
However, feed samples with no added CR or TC yielded more than 30 ppb of AF. In
addition, CR and TC down-regulated the expression of major genes associated with
AF synthesis in Aspergillus (P < 0.05).
During egg formation, AF residues could be transferred from the laying hen to
the fertilized eggs, thereby resulting in decreased embryo viability and hatchability,
and causing several organ malformations. Therefore, the second objective of this
dissertation was to determine the efficacy of CR and TC in reducing AF-induced
toxicity in chicken embryos. Results demonstrated that both phytochemicals
significantly decreased AF-induced toxicity in chicken embryos. At 75 ng of AF/egg,
CR and TC increased the survival of chicken embryo by ~ 55%. Moreover, CR and
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TC significantly improved the growth of embryos (tibia length and weight) when
compared to those injected with AF alone (P < 0.05).
Contamination of poultry feed with AF is a major concern to the poultry industry
since aflatoxicosis in chickens results in significant economic losses due to poor feed
utilization, decreased body weight, and increased mortality. Therefore, the third
objective of this dissertation was to evaluate the efficacy of CR and TC as feed
supplements in controlling aflatoxicosis in chickens. A total of 240 chickens were fed
with AF contaminated feed (~2.5ppm) with or without supplementation of 0.75% CR
or TC for 5 weeks. Results revealed that CR and TC supplementation in AFcontaminated feed ameliorated AF-induced adverse effects in chickens. In addition,
phytochemical supplementation significantly decreased relative liver weight and
improved relative bursa of Fabricius weight in birds, as compared to AF-treated group
(P < 0.05). Histologic analysis revealed that CR and TC reduced AF-induced toxic
effects in the liver of birds, where phytochemical-treated chickens had decreased
hepatocellular degeneration, necrosis and inflammation in the liver as compared to
chickens fed with AF alone.
Liver is the primary organ for AF detoxification, but it also initiates the toxicity
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of AF in the host. Among the 18 types of AF identified in feed, aflatoxin B1 (AFB1) is
one of the most potent hepatocarcinogens, where its active metabolite, 8, 9, -epoxide,
metabolized by P450 cytochrome in liver, binds to proteins and DNA and forms
protein- and DNA- adducts initiating the formation of hepatocarcinomas. In the fourth
objective of this dissertation, the effect of in-feed supplementation of CR and TC on
the hepatic transcriptome of chickens exposed to AF eas studied. Chicken livers were
collected from birds fed with AF contaminated feed (~2.5 ppm) with or without
supplementation of 0.75% CR or TC, and whole transcriptome profile of liver
samples from the control and treated chickens were analyzed using RNA-seq on
Illumina NextSeq 500 platform. Results revealed that pathways and genes that are
associated with hepatic diseases and lipid metabolism were affected by the AF diet
compared to control; however, supplementation of CR and TC to the AF diet
modulated several genes involved in these pathways.
To conclude, the results of this Ph.D. dissertation indicate that CR and TC could
be potentially used as feed additives to control aflatoxicosis in chickens.
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